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ABSTRACT 
Since 1986 in Western Australia many pharmacists have been supplying needles 
and syringes to injecting drug users as part of the governments's hann 
minimisation policy to prevent the spread of HIVI AIDS and other blood-borne 
viruses, particularly the more recently recognised hepotitis C. This practice was 
technically illegal, although officially condoned, until May 1994. Adequate 
baseline data not was available concerning needle and syringe supply or the 
attitudes of pha.rmacists concerning this issue. In this study a mail survey of 
Western Australian community pharmacists was conducted to determine the 
proportion of pharmacists currently supplying needles and syringes to injecting 
drug users, the factors that have influenced supply practice over time and the 
factors differentiating betwr.:en current sellers and nonsellers. A stratified random 
sample of 130 pharmacists was selected from the population of 466 metropolitrm 
and country pharmacists. Prior.to lho mail-out pharmacists were telephoned to 
inform them of the study, ask them to participate and ascertain their supply 
practice, after which questionnaires were posted to consenting pharmacists. Two 
follow-up calls were madeto non-respondents. From 129 forwarded 115 useable 
questionnaires were returned comprising 74 from the city and 41 from the 
country, a response rate of 88%. The results found that 88% of pharmacists were 
currently supplying needles and syringes to injecting drug users, 86% of 
metropolitrm and 90% of country pharmacists. Eight percent of pharmacists were 
past sellers and 4% had never sold. The commonest factors rated by current 
11 
· sellers as important in thei,. decision to supply needles and syringes was the belief 
that it was essential to the reduction of the transmission of disease ( 92%) and 
belief that disruption was unlikely to occur (78%). Disruption in their pharmacy 
(89'%) and threatening incidents (78%) were the main reasons past sellers ceased 
supply. The major differentiating factor concerning supply practice was that 
nonsellers were more likely than seUers to have experienced disruptive incidents 
in their pharmacy, r (113) ~ -.37 I!< .01. The fmdings indicate that the vast 
majority of pharmacists currently supply needles and syringes and were not 
unduly influenced by the fonner legal sanctions. There are some implications for 
support and/or training for pharmacists in relation to needle and syringe supply. 
iii 
,....,.._,..-""-'-.-.:"'',_,.,~.,-·-~:--::•;~.,.--~."'T"""""r••••,-:-_:~'"·~'7"'""''-''"7•...-,"''-':'"'~-.-.-~,....,........ ,..,.._.~~-<-_,.,..~.~---·---· ---
'•'• ~:-;·;-;;;.;:,..::-_-.:... -.,.,-
DECLARATION 
I certifY that this thesis does not incorporate without acknowledgement any 
material pr~viously submitted for a degree or diploma in any institution of higher 
education; and that to the best of my knowledge and belief it does not contain any 
material previously published or written except where due reference is made in 
the text. 
Sig
1'1· 6 ·/91?6" Date .................................................. . 
iv 
-----. ·---- ----·-· -··-····· 
ACKNOWLEDGMENTS 
For academic and professional input I panicularly want to thank Cetia Wilkinson 
from the Department of Health Studies who gave me the idea and, as my 
principal supervisor, helped immeasurably until motherhood beckoned. The breach 
was ably filled by David Ryder, who bad also been involved in the planning 
stages. These two, ever patient people, freely shared their knowledge and gave 
advice and support as they guided me through the research process. Their efforts 
are VeJy much appreciated. Others from the university to whom I owe a debt of 
gratitude are research consultants Tony Featherstonhaugh and Amanda Blackmore 
who helped with the research proposal and the analysis of data; Vicki Banharn 
from the Department of Human Services who contributed with information and 
advice and assisted with practicalities; and secretaries Sbirley Griggs from Health 
Studies and Linda Rogers from Hwnan Services who both helped with praetieal 
matters. Much appreciated was the input of Kathryn Keny from the 
Communicable Diseases Control Unit (formerly the AIDs Bureau), Sirnon Lento" 
from the National Centre for Research into the Prevention of Drug Abuse and Liz 
Dear from the Hepatitis C Council who freely assisted with information and 
suggestions during the planning stages of the research. Thanks also to the people 
who piloted the questionnaire. For practical and emotional support my family has 
been available throughout and I extend grateful thanks to them all, in panicular 
my daughter Jenny who helped with the mail out and was always there at the end 
of the phone with the understanding of a fellow student and a joke or two to keep 
V 
things in perspective. Special fuanks to my husband John, for proofreading the 
fmal draft and for his endless patience for the times I have not been available. 
Finally, thank you to the Phannaceutical Council of Western Australia and the 
Pharmacy Guild of Australia for their endorsement of the study and most 
particularly to their members, the pharmacists involved in the survey; their 
response was tremendous. 
DEDICATION 
To my Dad, who died before I had finished. 
VI 
TABLE OF CONTENTS 
Abstract 
Declaration 
Acknowledgments 
Dedication 
List of Tables 
List of Figures 
CHAPTER ONE 
Introduction 
The Purpose of the Study 
The Significance of the Study 
Research Questions 
Definition of Term 
Limitations of the Study 
CHAPfER1WO 
11 
iv 
V 
vi 
X 
xi 
I 
3 
4 
6 
6 
8 
Review of Related Literature 10 
Blood-Borne Disease I! 
HIV/AIDS 11 
Hepatitis 15 
Injecting Drug Use 19 
Needle Sharing 21 
Public Policy 23 
Harm Minimisation 24 
Harm Reduction Strategies 27 
Needle and Syringe Supply 29 
Western Australian Initiatives 29 
The Law 30 
Deterrence Theory 33 
Attitudes to Injecting Drug Users 35 
Previous Australian Studies 37 
Pharmacists' Perceptions of the Seriousness of HIV/AIDS 39 
Needle Supply Practices 41 
Difficulties Experienced by Pharmacists 44 
Review Summary 45 
vii 
CHAPTER THREE 
Method 
Organisational Support 
Research Design 
Sample of Subjects 
Questionnaires 
Pilot of the Questionnaires 
Content of the Questionnaires 
Reliability and Validity of the Questionnaires 
Procedure 
Initial Telephone Contact 
Mail Out 
Follow-up Telephone Calls 
Letters of Appreciation 
Response Rate 
Response to the Initial Telephone Call 
Response to the Study 
Ethica1 Considerations 
Data Analysis 
CHAPTER FOUR 
47 
47 
48 
49 
51 
51 
52 
56 
57 
57 
58 
59 
59 
60 
60 
60 
62 
63 
Results 65 
Sample Characteristics 65 
The Extent to Which Pharmacists Currently Supply 
Needles and Syringes to Injecting Drug Users 67 
Injecting Equipment Sold 68 
Pharmacy Policy 69 
Factors That Have Influenced Changes in Supply 
Practices Over Time 70 
Current Sellers 70 
Past Sellers 74 
Factors That Differentiate Between Current Sellers 
and Nonsellers 77 
Health Risks of HIV and Hepatitis C 79 
Health Hazard of Non-sterile Injecting Equipment 82 
Training 82 
Support of Health Department of Western Australia's 
Harm Minimisation Strategy 84 
Disruptive Incidents in Pharmacy 84 
Other Problems 88 
Current Legal Status of Needle and Syringe Supply 
to Injecting Drug Users. 89 
Attitudes to Injecting Drug Use and Injecting Drug 
Users 90 
viii 
Nonsellers' Current Reasons for Not Selling 
Other Issues 
CHAPTER FIVE 
Discussion 
The E>.1ent of Current Needle and Syringe Supply 
Factors Influencing Changes to Supply Practice 
Future Intentions 
Factors That Differentiate Between Current Sellers 
and Nonsellers 
HIV and Hepatitis C 
Effects of the Legal Status 
Deterrence Theory 
Attitudes to Injecting Drug Use and Injecting 
Drug Users 
CHAPTER SIX 
Conclusions 
REFERENCES 
Appendix A: Application for Approval of a Needle and 
Syringe Exchange Program 
Appendix B: Pharmacy Guild of Australia Survey Approval 
Appendix C: Initial Telephone Interview Format 
Appendix D: Current sellers' Questionnaire 
Appendix E: Nonsellers' Questionnaire 
Appendix F: Pilot Form 
Appendix G: Recording Form 
Appendix H: Cover letter 
Appendix I: Format for First Telephone Call-hack 
Appendix J: Format for Second Telephone Call-back 
Appendix K: Thank You Letter to Pharmacists 
Appendix L: Alternate Thank You Letter to Pharmacists 
Appendix M: Thank You Letter to Pharmacy Guild of Australia, 
National Services Branch 
Appendix N: Thank You Letter to Pharmacy Guild of Australia, 
\\'estern Australian Branch 
Appendix 0: Thank You Letter to Pharmaceutical Council of W.A. 
Appendix P: Flowchart of Pharmacists' Response 
91 
93 
94 
94 
96 
97 
98 
99 
100 
101 
102 
103 
105 
113 
114 
116 
117 
129 
143 
144 
146 
147 
148 
149 
150 
151 
152 
153 
154 
IX 
LIST OF TABLES 
Table I. Previous Australian Studies. 38 
Table 2. Phannacy opening . ours. t\6 
Table 3. Supply practice of participants by location. 68 
Table 4. Main points of phannacy policy. 69 
Table 5. Year phannacists began supplying needles and syringes 
to injecting drug users. 71 
Table 6. Correlation between selling practice and possible 
influencing factors. 78 
Table 7. Disruptive incidents experienced by phannacists. 85 
Table 8. Strategies use by phannacists experiencing disruptive 
incidents. 87 
Table 9. Current legal status of needle and syringe supply to 
injecting drug users. 90 
X 
UST OF FIGURES 
Figure I. Factors influencing current sellers' decision to sell. 73 
Figure 2. Factors influencing past sellers' decision to stop 
selling. 76 
Figure 3. Current sellers' view of the seriousness of HIV and 
hepatitis C to the general public and to injecting 
drug users. 80 
Figure 4. Nonsellers view' of the seriousness of HIV and 
hepatitis C to the general public and to injecting 
drug users. 81 
Figure 5. Current sellers' view of how significant a health 
hazard the use of non-sterile injecting equipment is 
to the general public and to injecting drug users. 83 
Figure 6. Nonsellers' view of how significant a health hazard 
the use of non~sterile injecting equipment is to the 
general public and to injecting drug users. 83 
Figure 7. Factors influencing nonsellers' current decision 
not to sell needles and syringes to injecting drug 
users. 89 
XI 
.....,~ ..... -,-,~::e~-~~---~~'7'"':';~~··,-.,.-----::~~-~"'----..-..,,.._,..,~~~~-,.,._,.,.-~·--·~--~------- --
........ , ... : ,., --·- --
CHAPTER ONE 
Introduction 
Since 1987 pharmacists in Western Australia have been encouraged to sell 
needles and syringes to injecting drug users as part of the governments harm 
minimisation strategy for the prevention of the spread of the human 
immunodeficiency virus (HIV). the organism that causes the auto immune 
deficiency syndrome (AIDS) (Loxley et al., 1990). With the more recent 
identification of another serious blood-borne virus, hepatitis c. and its rapid 
spread among the injecting drug using population, it has become more imperative 
that preventive measures such as the sale of sterile injectbg equipment by 
phannacists 11be implemented with greater consistency and C<'Verage" (\V odak & 
Crofts, 1993, p. 18). 
By early !994 the majority of pharmacies across the state (approximately 78%) 
were selling needles and syringes to injecting drug users (Kerry, 1994). While this 
couJd be regarded as a positive response to the government's initiatives there were 
still a significant minority who did not supply. It was known that some non-
selling pharmacists had never adopted this controversial practice, while others, 
having undertaken it, had reversed their decision to sell (Greig, !992). There was 
I 
however, no good baseline data available concerning the factors that affected 
supply practices nor of the attitudes of pharmacists in relation to this issue. 
Neither was there any data avaiiable concerning the proportion of metropolitan 
and country pharmacists supplying needles and syringes to injecting drug users in 
Western Australia 
While the supply of il\iecting equipment to illicit drug users was condoned for 
public health reasons in Western Australia, it was technically illegal under section 
36 of the Poisons Act 1964- Aiding and Abetting Drug Offences and section 6 
(2) of the Misuse of Drugs Act 1981 -tu incite or conspire with another to 
commit an offence (Keny, 1994). It was within this con\ext that this research was 
planned with the question in mind of how the legal situation influenced 
pharmacists' supply practices. At that time however, the Poisons Amendment Bill 
1993 was expected to proceed to the third reading in the Legislative Assembly of 
the Western Australian Parliament in March 1994, after which it was anticipated 
the Act would be proclaimed, legalising the provision of needles Md syringes in 
Western Australia under certain conditions (Kerry, 1994). There was no certainty 
that the Bill would be passed as it had been rejected a number of times 
previously. However, the outcome of the Parliamentary deliberations was that the 
Bill was assented to on 15 April, 1994 by both houses of the Western Australian 
State Government as the Poisons Amendment Act 1994 (amending the Poisons 
Act 1964 and the Misuse of Drugs Act 1981) (Poisons Amendment Act, 1994) 
and proclaimed on May 24, 1994 (Proclamations, 1994). This meant that by the 
2 
time data was collected for this study it was legal, with the approval of the 
Commissioner of Health, to supply needles and syringes to injecting drug users. 
Consequently the timing of this study is important because it was conducted ji.!St 
after the legislation change and could determine whether the previous legal 
situation, in the context of the lack of enforceroent, had impacted on supply 
practices and offer some insight into whether the change in legislation would 
make a difference in the future. 
The Pul]lOse of the Study 
This study was conducted to determine the attitudes and practices of West em 
Australian pharmacists regarding the supply of needles and syringes to injecting 
drug users. The study was designed to establish the proportion of metropolitao 
and country pharmacists currently supplying needles and syringes to injecting 
drug users, the factors influencing current supply practices and factors that have 
influenced supply practices over time. The type of information sought included 
pharmacists' perceptions of the seriousness of HIV and hepatitis C as a public 
health concern; their thoughts on the supply of needles and syringes to injecting 
drug users; the policy and practice in their pharmacy regarding the sale of needles 
and syringes and the factors influencing past, present and possible future supply 
practices; and whether problems or difficulties had been encountered in their 
pharmacy involving illicit drug users. Other information sought pertained to the 
dispensing of methadone, pharmacists' understaoding of the legal status of 
supplying needles and syringes to injecting drug users and the influence this had 
--.·-- --·-~·-...----,_,.., . ........,,._7'---~<";---,_,__..,..,,__,~...-~,..,......,..., . ....___,~-~~--~-------­
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on supply practices, attitudes to injecting drug use and injecting drug users and 
demographic details. 
The Sh:nilicance of the Swdy 
This research is significant because it is the first comprehensive study to be 
C{)nducted in Western Australia to determine pharmacists' attitudes and practices 
to the supply of needles and syringes to injectin£ drug users. The one small 
unpublished study that surveyed pharmacists in relation to this issue was an 
evaluation of the pharmacy 'Fitpack' program (Greig, 1992). Greig's (1992) 
research, however, did not address the issue of the locality of pharmacists or their 
atti~udes to the provision of need1es and syringes to injecting drug users. The 
results of the current study redresses a gap in knowledge and provides good 
baseline data tha: could have implications for poliey and prc "\lee in regard to the 
future supply of needles and syringes as well as other health initiatives. 
A further significant feature of the study is that there has been no previous 
research conducted which focuses on the beliefs and attitudes of phannacists in 
reJation to hepatitis C, although several studies of a similar nature in other states 
have concentrated on HJV (Cuatt, 1989; Jennings, 1987; Tsai, Gob, Webeck & 
Mullins, 1987). Considering this, Western Australian pharmacists' perceptions of 
the seriousness of hepatitis C is an important aspect of this study. The fmdings 
should give some indication of the extent to which hepatitis C is understood and 
will be of interest to health professionals and policy-makers alike. 
4 
Some phannacists experience problems and/or difficulties in conducting their 
business with regard to the sale of needles and syringes to injecting drug users 
(Greig, 1992; Monash Medical School, 1987). An important element of this 
research is determining the extent to which pharmacists are experiencing problems 
and difficulties and how they are handling incidents, and identifYing areas of 
concern. Highlighting these factors may offer some insight into the need for 
support and/or training for phannacists. 
By supplying needles and syringes to injecting drug users phannacists are 
providing a valuable service in the interest of public health. According to Lenton 
( 1994) however, in the view of some phannacists: 
there was little public acknowledgement of the work (they] have undertaken, 
largely out of goodwill, in ntinimising the impact of HJV and other blood-
borne diseases on the community through participation in the scheme to 
provide. [needles and syringes] to [injecting drug users]. (p. 3) 
Therefore this research is significant for pharmacists who feel they have never 
really been recognised for the service they are providing. Participation in this 
project provides the opportunity for them to express their views and recount their 
experiences in a formal manner, thus contributing valuable information to help 
identifY key variables that could impact on policy or procedure that personally 
effects them. 
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Researeh Questions 
This study endeavours to answer three broad questions: 
I. To what extent do pharmacists currentiy supply needles and syringes to 
injecting drug users? 
2. What are the factors that have influenced changes in the supply 
practices of pharmacists? 
3. What are the factors that differentiate between pharmacists who currently 
supply of needles and syringes to injecting drug users and those who do not 
supply? 
Definition of Terrus 
Injecting drug users In this study the term "injecting drug users11 refers to persons 
who inject drugs illicitly. It does not include persons injecting drugs for legitimate 
health reasons, for example diabetics, unless specifically stated. 
Hl!nn minimisation The National Drug Strategy Conunittee (1993) describes 
harm minimisation as: 
an approach that aims to reduce the adverse health, social and economic 
consequences of alcohol and other drugs by minimising or limiting the 
banns and hazards of drug use for both the community and the individual 
without necessarily eliminating use. (p. 4) 
The tenn 'harm minimisation' refers to the broad policy or approach and is 
defined by Strang (1993?) as "the overall goal or endpoint to be aimed for" (p. 7). 
6 
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Hann reduction Harm reduction refers to the programmes and strategies 
implemented to achieve the goals of harm minimisation (Strang, 1993?). For 
example, supplying needles and syringes to injecting drug users is a harm 
reduction strategy. Other strategies pertinent to the prevention of blood-borne 
disease include educating injecting drug users of the potential danger of their 
activities and ways to minimise their risk, and methadone programmes for opiate 
dependent users. 
Fitpack A Fitpack is a black plastic pack which holds five needles and syringes 
providing a safe and convenient method of storing and carrying, frrst sterile, then 
used needles which may be locked securely in place and the Fitpack safely 
dispesed of. 
Current SeUeJS Current sellers are pharmacists who were selling needles and 
syringes to injecting drug users at the time data was collected for this survey. 
Pll'lt selleJS Past sellers are pharmacists who had previously sold needles and 
syringes to injecting drug users and no longer do so. 
Never Sold The tenn 'never sold' refers to pharmacists who have never sold 
needles and syringes to injecting drug users. 
7 
Nonsellem Nonsellers are phannacists who do not currently sell needles and 
syringes to injecting drug users. They include past sellers and phannacists who 
have never sold. 
limitations of die Study 
The timing of this study may be a limitation because it was conducted so soon 
after the legislative change that removed the sanctions r~:garding the provision of 
needles and syringes to injecting drug users. Some pbannacists were reacting to 
having to apply for approval and may have been in a state of uncertainty about 
their legal position (K. Keny, personal communication, October 1994) which may 
have affected some of the responses received. Although it Wl<S known at the 
planning stage that the change was highly probable it was hoped that the study 
could have been conducted prior to the event or some months after. However, the 
timing of the change and time constraints of the study prevented this. 
As the total population of phannacists was not surveyed a further limitation of the 
study is that there is no way of knowing whether the sample selected was 
representative of all phannacists in Western Australia, thereby enabling accurate 
generalisation. However, the random sampling technique and the high response 
rate would indicate that this is not a serious limitation (de Vaus, 1991). 
Self-report bias may also be a limitation. As de Vaus (1991) points out "responses 
to sensitive or controversial questions can be affected by social desimbility 
8 
considerations: giving acceptable rather than true opinions" (p. 110). However, 
according to Dillman ( 1978), of all self report type surveys mail surveys have the 
least probability for socially desirable answers. 
9 
CHAPfER TWO 
Review of Related Utemture 
This review presents the background to the harm reduction strategy to supply 
needles and syringes to injecting drug users, the Western Australian experience 
and a review of previous Australian studies relating to pharmacists' supply of 
needles and syringes. Firstly, an overview of the blood-borne diseases HIV/A!Ds 
and hepatitis C is presented, followed by a discussion on injecting drug use. 
Government po1icy in response to these diseases is described explaining hann 
minimisation and hann reduction strategies, and more particularly the provision of 
sterile injecting equipment to injectjng urug users. The Western Australian 
experience is discussed particularly in relation to phannacists' role in needle and 
syringe supply, and in the legal situation concerning supply. Deterrence theory, 
which may be an influence on pharmacists' supply practices is also discussed. 
This is followed by a discussion on attitudes to injecting drug users. The chapter 
concludes with a review of previous Australian studies concerning pharmacists 
supply of needle and syringes to injecting drug users. 
10 
Blood-bome Disease 
AIDS 
Since the first cases of AIDS in the western world were diagnosed in the United 
States in 1981 a world wide health crisis has evolved due to the epidemic spread 
of the disease, the phenomenon now being classed as a "global paodemic" 
(National HIV/AIDS Strategy: 1993-94 to 1995-96, 1993, p. 5). The first 
identified cases of AIDS were among men who have sex with men, believed to 
have been transmitted through anal sex, with the first wave of the epidemic 
spreading mpidly through the male homosexual/bisexual population in many 
develofk.'<l countries of the world (Department of Community Services and Health, 
1989). 
Early in the epidemic it was recognised that injecting drug users were also 
contracting HIV through sharing contaminated injecting equipment (Schuster, 
i 992). A second wave epidemic among the injecting drug using population swept 
through many countries including America, Europe and Asia (Des Jarlais, 1992; 
Darke, 1992; Wodak, Crofts & Fisher, 1993). The experience of cities such as 
New York (Des Jarbis & Friedman, 1990), Edinburgh (Robertson, 1990), Milan 
(Tempesta & Gianntonio, 1990) and Manipur (Naik et al., 1991), with HIV 
seroprevalence rates among injecting drug users increasing to over 50% in the 
space of a few years, well illustrates the rapidity with which HIV can spread once 
established within a population of drug injectors. Des Jarlais (1992) contends that 
"a lack of AIDS awareness" among drug injectors &..."1d "meci,anisms for efficient 
11 
mixing of the at-risk population" appear to be the most frequently identified 
factor.; in the rapid spread of HIV (p. 34 7). 
Because AIDS was fir.;t identified in the developed world among men who have 
sex with men and among injecting drug users, it was initially assumed that 
transmission was associated with male to male sex and with unsafe injecting 
practiceo (National HIV/AIDS Strategy: 1993-94 to !995-96, 1993). However, 
subsequent discovery of extensive heterosexual transmission of HIV in Afiica 
changed this perspective and in recent years in the United States the proportion of 
AIDS cases due to heterosexual contact has risen sharply (National HIV/AIDS 
Strategy: 1993-94 to 1995-96, 1993). 
In the western world injecting drug users are the "major conduit for the 
dissemination ofHfl/ infection to the general community" (Wodak, 1990, p. 22) 
by transmission from infected persons to their sexual partners, and perinatally 
from mother to child (Kaldor, Elford, Wodak, Crofts and Kidd, 1993). This is 
well illustrated in New York City where, by 1988, injecting drug users were the 
source of infection in over 90% of heterosexual and over 80% of maternal~ infant 
cases of AIDS (cited in Wodak, Crofts & Fisher, 1993). As Wodak (1990) points 
out: 
The control of HIV infection in the third wave of the AIDS epidemic - i.e. 
in the non-drug using heterosexual community - will depend, in most 
western ~untries, on the success or failure of efforts to control the second 
wave of the epidemic - i.e. the spread of HIV in injecting drug users. (p. 22) 
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Prevalence of HIV/AIDS in Austmlia. 
From the time AIDS was frrst recognised in Australia il' 1982 (Wodal~ 1992) 
until June 30, 1994 according to figures from th'~ Australian HIV Surveillance 
Rewrt (National Centre in Epidemiology and Clinical Research, 1994a), a 
cumulative total of 18,274 diagnosed cases ofHIV infection were officially 
reported. Of these 4,882 had developed into AIDS. Eighty one percent of cases 
were reported to have been contracted through male homosexual/bisexual contact, 
5.2% through injecting drug use, and a further 2.9% of cases were among 
homosexuaVbisexual males who also injected drugs. Over the years an increasing 
number of heterosexnals have contracted the virus with only 1.3% of total cases 
reported up to 1985 compared with 14.2% during 1993 (National Centre in 
Epidemiology and Clinical Research, l994b). The proportion of reported cases 
associated with injecting drug use in 1993 was 4.7%. 
New South Wales, the state in which HIVIAIDS was first diagnosed (Wod~ 
1992), has the highest prevalence ofHlV/AIDS with 63% of cumulative cases 
reported to December 31, 1993 (National Centre in Epidemiology and Clinical 
Research, l994b). This figure reflects the fact noted by Tsai, Gob, Webeck and 
Mullins (1988) that while New South Wales has approximately one third of the 
Australian population it b'IS an estimated 50% of the total intravenous heroin 
users in Australia. Another factor in the high proportion of HIV in New South 
Wales is the substantial homosexual community in the state, particularly in 
Sydney, which has an identifiable gay district in the inner city (Wod~ 1992). 
l3 
Following New South Wales, Victoria with approximately one quarter of the 
Australian population (Castles, 1993) has 19"/o of cumulative cases ofHN, 
Queensland with 17% of the population has 9% of cumulative HIV cases and 
Western Australia with one tenth of the population has 4% of cumulative cases of 
HIV. The other states and territories have less cases of HIV in proportion to their 
population. 
Prevalence of HIV/AIDS in Western Australia. 
Figures from the Epidemiology and Health Statistics Section of the Health 
Department of Western Australia reveal that since the first cases were recognised 
in this state in 1983, there have been 823 notifications ofHN until March 1994, 
155 of which have developed into AIDS (M. Ashwell, personal communication, 
March 18, 1994). Of all cumulative HIV cases 73.5% were among homosexual 
and bisexual men. Another 5.9% were associated with injecting drug use as a 
single risk factor (4.1% being males and 1.8% females) which increased to 12.1% 
when men who h~ve sex with men were taken into account. ;\{eterosexual 
transmission of the virus accounted for 8.8% of cases. 
Prevalence of HIV/AIDS amo112 injecting drug use111. 
As previously mentioned the incidence ofHIV/AIDS among drug injectors is over 
50% in some overseas cities. In eddition to this, Des Jarlais (1992) notes that drug 
injectors are the largest single group of persons with HIV/AIDS in many cities 
and countries, including New Jersey and Connecticut in the United States, 
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Edinburgh in Scotland, Spain, Italy, Thailand and China In comparison, in a 
review of twelve Australian studies which measured the prevalence of HIV 
infection among injecting drug users Kaldor, Elford, Wodak, Crofts, & Kidd 
(1993) foWld that HIV seroprevalence among this population has been low, at 0 
to 5%. However, among male injecting drug users who also had sex with men 
HIV prevalence ranged from 20% to 24%. In a Perth study Loxley, Marsh, 
Hawks, & Quigley (1992) found the prevalence ofHIV in a sample of Western 
Australian injecting drug users was quite low with 2.2% of the participants testing 
positive for the HIV antibody. 
Wodak (1992) claims that while the number of AIDS cases in Australia are 
relatively low compared to many other parts of the world, possibly due to the 
initiatives of the government in relation to the prevention of the disease, we 
cannot become complacent. The National Evaluation Steering Committee (1992) 
agrees and asserts that: 
effort needs to be kept up to maintain adequate levels of safe bohaviour in 
the long term - the epidemic is still young and unstable and the potential for 
renewed rapid spread still exists. To do otherwise would be hazardous. (p. 
9) 
Hepatitis C 
Another serious blood borne-virus, Hepatitis C which affects the liver, was 
identified in 1989 (Frankis, 1994) and is also reaching epidemic proportions, 
particularly among injecting drug users. According to the Australian 
Gastroenterology Institute (1994) hepatitis C is responsible for at l<HSl 95% of 
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cases of chronic Non-A Non-B hepatitis. More than 50% of individuals exposed 
to the virus become chronic carriers with at least 25% of cases developing into 
chronic liver damage, resulting in cirrhosis and in some cases liver cancer. 
The most efficient transmission of hepatitis C is by blood to blood contact, and 
less efficiently sexually (Crofts, et a1., 1993., Australian Gastroenterology 
Institute, 1994). Current information from the Australian Gastroenterology 
Institute (1994) reveals that in Australia, of patients infected with hepatitis C, 
about 60% have acquired the infection by shatiug contaminated injecting 
equipment during drug use and another 25% from transfusion of blood or blood 
products prior to February 1990. However the incidence of sexual transmission 
from a person with chronic hepatitis C infection appears to be low and much rarer 
than for HIV and hepatitis B although there are indications that persons with 
acute hepatitis C may be more likely to transmit the disease sexually. 
Prevalence of hepatitis C 
It has been estimated that there are 500 million people infected with hepatitis C 
around the globe, with estimates in Australia varying between 80,000 and 
200,000, according to Frankis (1994). This represents a far greater prevalence of 
hepatitis C than HJV and Wodak and Crofts (1993) report estimates of at least 
five times more people infected with hepatitis C in Australia than there are 
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ilifected with HIV. Moreover, there are at least 15 times more new infections of 
hepatitis C each year compared to HIV. 
The Australian Gastroenterology Institute (1994, p. 3) reports that among overtly 
healthy Au•tralian blood donors, the hepatitis C viral canier rate is 0.2% - 0.4%. 
However, it is noted that due to the screening of those blood donors at special 
risk of hepatitis C, prevalence may be higher in the general population. It is 
however, the iqjecting drug using population that is most affected by hepatitis C 
in Australia, with history of past or present injecting drug use being the 
commonest risk factor for contracting the virus (Kaldor et a!, 1992; Wodak & 
Crofts, 1993). For persons who have ever injected drugs the risk is 70%, 
increasing to 90% amongst those using drugs intravenously for more than two 
years at an earlier stage in their lives (Australian Gastroenterology Institute, 
1994). 
Studies in other developed countries (cited in Crofts et al. 1993) have shown 
hepatitis C seroprevalence rates among injecting drug users of 500/o to 80%. In 
Australia, a Victorian cohort study conducted by Crofts and his colleagues (Crofts 
et al., 1993) found that 68% of injecting drug users were infocted with hepatitis 
C, risk being particularly associated with length of injecting. In an earlier study in 
New South Wales, Bell and his associates had reported an even higher incidence 
of hepatitis C among a sample of injecting drug users with 86% of subjects 
testing positive (Bell et al., 1990). In this study it was found that approximately 
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two thirds of injecting drug users became hepatitis C positive within two years of 
commencing regular intravenous drug use with 100% seropositivity among 
persons injecting drugs for more than eight years. As Bell and his associates (Bell 
et al., !990) point out, these figures indicate that youog people who experiment 
with illicit drugs are at significant risk of contracting hepatitis C. 
Prevalence of hepatitis C in Western Austmlia. 
Estimations have been made that between 10,000 and as many as 30,000 people 
in Western Australia may be infected with hepatitis C, with prosent and former 
injecting drug users, hlood product recipients, "'d migrants who had shared· 
needle immunisations overseas being the main groups affected (Treweek, 1994). 
While hepatitis C only became a notifiable disease in Marct 1993 in Western 
Australia, a total of 1526 cases were reported by April 20 1994 (Treweek, 1994). 
Of clients tested in the Perth methadone clinic 85% to 90% tested positive for 
hepatitis C (Kerry, 1994) indicating that the incidence of hepatitis C in the 
injecting drug using population in Western Australia is extremely high. 
While transmission of hepatitis C is similar to HIV, Hulse, Moore and Lambert 
(1993) assert that due to the low incidence ofHIV in Australian injecting drug 
users the risk of infection during any single needle sharing incident remains 
relatively low. Conversely, with the high incidence of hepatitis C among persons 
injecting for longer that four years, "the likelihood that hepatitis C transmission 
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and infection will result from a single sharing of injecting equipment is extremely 
high" (p. 635). 
Although the incidence of HIV among people with a history of injecting drug use 
relllllins low, it is rising gradually (Kerry, 19Q4). Furthermore, with the prevalence 
of hepatitis C within the Western Australian injecting drug using population 
"alarmingly high" (Donoghoe, 1994, p. 31) it is clear that measures to prevent 
transmission of these blood-borne diseases should continue to be supported and 
developed. 
Injecting Drng Use 
While it is difficult to accurately assess the prevalence of injecting drug use it 
appears there are an increasing number of injecting drug users in Australia. For 
example, by extrapolating from the findings of a national household survey 
conducted in 1986-87 Spooner (1988) estimated that the number of adult injecting 
drug users at that time was 172,000. More recent figures from the 
Intergovermnental Committee on AIDS (1992) estimated there were 200,000 
injecting drug users in Austr•Jia. According to Crofts and Wodak (1993}, in 1993 
an estimated 200,000 people (representing 2.4% of the adult population) had 
injected drugs at least once in the previous 12 months. Crofts and Wodak (1993) 
further report that an exponential increase in the drug related crime rate during the 
1980's in Australia suggested a rapid increase in the number of people injecting 
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drugs with a possible average recruitment of 1 0'/o, with 5% leaving the injecting 
drug using population ann••ally. 
Numbers for people injecting drugs in Western Australia have been estimated at 
2,500 to 5,000 regular and 10,000 to 12,000 recreational irtiecting drug users 
(Schwartzkoff and Watchirs, 1991). Researchers have been cautious about making 
estimates of prevalence over more recent years in Western Australia but indirect 
drug use measures tend to suggest it is increasil. ~ (Lenton, 1993). 
One possible explanation for the growing number of injecting drug users in 
Australia is that since the mid 1980s the prevalence of amphetamine use has 
clilnbed (Reilly & Home!, 1988) with a resulting increase in the number of drug 
users choosing injection as the mode of administration (Aisbett, 1991; Hall & 
Hando, 1993, Hando & Hall, 1994). Spooner, Flaherty and Home! (1993) 
confirmed this trend when they found that, of a street intercept sample of young 
Sydney illicit dm~ users, amphetamines were the most commonly used illicit drug 
after marijuana with 61% of the sample having used amphetamines in the 
previous three months, one third of whom had injected the drug. According to 
Lenton (1993), from 1991 to 1993 amphetamine use became more prevalent 
nationally among the 20 to 25 year age group, particularly males and in Western 
Australia indirect measures, including arrest and seizure data, suggest 
amphetamine use has increased over recent years. Indeed, three years ago in 
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Western Australia fears were expressed in the media of the possibility of an 
increase in the spread of HIV due to the upsurge in amphetamine use among 
young people (Aishett, 1991). More recently the Western Australian Director of 
Public Prosecutions issued warnings that Perth was "awash with amphetamines" 
(cited in Lang, 1995, p. I). 
The cost of street drugs and their impurity is also a principal factor in the number 
of drug users injecting drugs rather thllil using alternative routes of administration 
(Wodak, 1989). In places where drugs are less expensive and of higher purity 
users will also sometimes inhale or ingest their drugs. This is the case in 
Amsterdam where it is estimated that at least 60% of heroin and cocaine users do 
not inject but inhale, or 'chase the dragon' (Buning, van Brussel & van Santen, 
1992). With the increasing prevalence of persons injecting drugs in Australia the 
potential to further fuel the HIV/AIDS and hepatitis C epidemics, through unsafe 
practices, is enhanced. 
Needle Sbarine 
While injecting drug use is not in itself a risk factor in the spread of AIDS and 
hepatitis C the sharing of contaminated injecting equipment is. The extent to 
which injecting drug users share needles and syringes are dependent upon a 
number of factors. Studies have found that the most common reason given for 
sharing has been the difficulty in obtaining new equipment (Australian National 
AIDS and Injecting Drug Use Study (ANAIDUS), !992; Edgoose & Baillie, 
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1987; Ingold & Ingold, 1989; Lmdey et al, 1992). The social context of drug use 
(ANAIDUS, 1992) and broad social nonns within the drug culture such as 
neighbourliness and mutual support also influence needle sharing (McKeganey & 
Barnard, 1992). Laws regulating the sale and possession of needles and syringes 
also effect needle sharing practices (Tsai et al., 1988; Anderson, 1991). Other 
reasons given for sharing include unavailability of clean equipment at times of 
urgency or desperation (ANAIDUS, 1992; Ingold & Ingold, 1989) and lack of 
motivation to obtain new equipment (Edgo~>se & Baillie, 1987). 
McKeganey and Barnard (1992) and Loxley et al (1992) found that most needle 
sharing involves sexual partners, close friends or family members who are 
considered 'safe'. It appears that women injectors, who tend to have injecting 
partners (Kiee, 1993), may be more vulnerable to risk of infection with HIV and 
hepatitis C than their male counterparts, through sexual transmission and the more 
frequent sharing of their partner's used equipment (Barnard, 1993; Klee, 1993). 
Considering this, the possibility of further transmission to unborn infants is 
increased. 
Studies reveal a decrease in HIV risk behaviour; among injecting drug users, by 
either no longer injecting or reducing the incidence of equipment sharing 
(ANAIDUS, 1992; Loxley et al, 1992; Power, Hartnoll & Daviaud, 1988; Ronald, 
Roberton & Roberts, 1992; Ross, Stowe, Wodak & Gold, 1993; Saxon, Calsyn & 
Jackson, 1994). However, as Wodak (cited in Loxley et a!, 1992) points out: 
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although there are consistent local and international reports of reductions in 
unsafe injecting, and to a lesser extent sexual, practices, the baseline levels 
of these behaviours is very high, and relapse to HIV-related risk behaviour 
is increasingly recognised as a problem. (p. 691) 
In Perth, Western Australia, results of the ANAIDUS study conducted by Loxley 
and her colleagues (Loxley et al, 1992) revealed that while respondents reduced 
their unsafe injecting to some extent, their needle sharing behaviour still placed 
them at a high level of risk of HIV. As there is a greater possibility of contracting 
hepatitis C than HIV in Australia these iryecting drug users are at even greater 
risk of contracting a serious blood-borne disease. 
Public Policy 
Australia's response to the threat of the HIVIAIDS epidemic was led first by the 
homosexual community, followed by federal and state governments and other 
communities, leading to the development of a range of comprehensive policies 
culminating in the National AIDS Strategy (National Evaluation Steering 
Committee, 1992). One of the earliest committees formed was the National 
Advisory Committee on AIDS (NACAIDS) which was set up in 1984 to advise 
on educational, legal and social issues related to the epidemic and which made a 
substantial contribution to early education and allaying the public's fears about 
HIV/AIDS. From 1984 to 1987 the National AIDS Task Force was the guiding 
medical and scientific organisation. These two bodies were replaced in 1988 by 
the Australian National Council on AIDS. As the National Evaluation Steering 
Committee (!992) points out, Australia's response to HIV/AIDS has been 
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characterised by "strong national leadership and political commitment" (p, 19) 
with this country being one of the few countries to have a National HIV I AIDS 
Strategy . 
Harm Minimisation 
In view of the incurable nature of HIV/AIDS the federal government in Australia 
adopted a prevention approach to the transmission of the disease. A critical factor 
in this response was the National Campaign Against Drug Abuse in 1986 with its 
principle aim "to reduce the harmful effects of drugs on A11stralian society" 
(Biewett, !987). The principle of harm ntinimisation recognises that there is a 
broad spectrum of levels of drug use, acute and chronic, and of associated risks 
and physical harm (National Drug Strategy Cornntittee for the Ministerial Council 
on Drug Strategy, 1993). People everywhere use drugs of one kind or another for 
different reasons, and most drugs can be used in ways that are safe or ways that 
are harmful, and also in ways that are deadly ("Harm reduction", 1991), With this 
in mind the concept of harm reduction was perceived as a more realistic aim than 
the unachievable goal of a drug free society (Wodak, 1992). There was also a 
growing belief throughout the 1980s that a hann minimisation approach was more 
realistic than the more rigid medically based ideas of "treatment', "cure" and 
"abstinence" (Berridge, 1990, p. 343) which had previously dontinated. 
While not abandoning the old strategies new ones emerged in response to more 
enlightened ;:md realistic thinking about drug use, For example Prochaska and 
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DiCiemente (1986) suggested that drug users go through a number of stages in 
the process of change. These included precontemplation (when persons are not 
contemplating change and are resistant to it), contemplation (thinking about 
changing and weighing up the pros and cons of continued using and abstaining), 
action (taking action to stop using) and maintenance (maintainir1g change and 
preventing relapse). More recently another stage, preparation (intending to change 
in the near future), has been included between contemplation and action 
(Prochaska, DiCJemente & Norcross, 1992). An individual may move forward or 
relapse to a fonner stage. The previous ideas of treatment, cure and abstinence are 
useful strategies for persons who are in the action and maintenance stages of 
change. Precontemplaters, however, don't want to change; contemplaters are 
ambiva1ent about it; and preparers are not quite ready. so it is for these 
individuals that harm reduction strategies may be most appropriate. 
Moreover, the phenomenon of natural remission from drug dependence and 
addiction was becoming increasingly recognized (Peele, 1989). In the case of 
heroin Winick (cited in Peele, 1989) had found as early as the 1960s that most 
adolescent and young adult heroin addicts in New York outgrew their addiction 
by their mid-thirties. More recently Stimson and his colleagues (Stimson, 
Oppenheimer & Thorley, 1978) found in a follow-up study of heroin 'addicts' 
known to have attended London drug dependence clinics seven to eight years 
earlier that at least 40 people out of the original cohort of 128 had achieved 
abstinence, the large majority having no treatment after withdrawal. This maturing 
25 
out, as the phenomenon has become known, demonstrates the human potential for 
change and "provide[s] an antidote to long-indoctrinated images of the ever-
deepening spiral of heroin addiction" (Peele, 1989, p. 176). Waldorf ( 1983) too, 
could see the possibility for change and declared that dependent users or 'addicts' 
(especially heroin 'addicts') are caught in a pattern of abstinence and relapse, that 
ends up in either death or a stable, drug free life. By minimising the harm 
associated with the use of drugs, individuals are helped through a phase in their 
lives and have the chance to hopefully overcome their drug use in the future 
through either treattnent or natural recovery (Waldorf, 1983) without contracting a 
life-threatening disease. 
With the advent of IDV and hepatitis C the potential dangers of injecting drugs 
were enhanced markedly, in light of the deadly nature of the diseases. 
By introducing harm reduction strategies to help prevent infection with these 
viruses, injecting drug users may live long enough to stabilize their lives. For as 
Dave Purchase, the Director of an illegal needle exchange in Tacoma, Washington 
in the United States said in relation to HIVIAIDS and injecting drug use: "you 
can overcome being stupid, but you can't overcome being dead" (cited in "Harm 
Reduction Conference", 1992, p. 21 ). 
Furthennore, it was recognised that there were a :mbstantial number of non-
dependent drug users in the community (Spooner, 1988) who were at potential 
risk of contracting and transmitting disease to others. In outlining some of the 
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characteristics of the injecting drug using population Spooner (1988) categorised 
these users as dependent users; non-dependent regular users; and non-dependent 
rt."Creational, occasional and experimental users and suggests that the non· 
dependent users represent a much larger proportion of the total of injecting drug 
users. Moreover. individuals were known to move between categories and 
between using and non-using status. Although the incidence of HIV among 
dependent users may be greater, the non-dependent group being numerically 
larger possibly have the greater potential for viral transntission (Spooner, 1988). 
All of these factors, plus the increasing concern of health workers and the general 
public over the spread of AIDS which was a major impetus to the decision to 
adopt a harm minimisation policy (Luger & Batey, 1993), have impacted on the 
adoption and acceptance of the pragroatic approach of the Australian Government 
towards the prevention of HIV/AIDS and hepatitis C. And, as Luger and Batey 
(1993) add, "few would have problems accepting the notion that substance users 
should be spared serious, destructive consequences associated with their activities'' 
(p. 3). 
Bann Reductio• Stmtegies. 
In the realm of HI V/AIDS, harm ntinimisation took two forms, education and 
prevention, in an effort to eliminate transmission of the virus (Department of 
Comrnuoity Services and Health, 1989). Education was targeted to specific groups 
which included penple whose activities placed them at greater risk of infection -
27 
- ' - - " ' . -
,.; '·"'·--~· .. ,-<,·->~----·.-.;.---
and those affected - including homosexual/bisexual males and injecting drug 
users; carers of people with HIV including professional care givers; and the 
general community. Safer sexual practices were advocated which included 
alternatives to intercourse and the use of condoms. In relation to the injection of 
drugs, strategies for avoiding unsafe drug use involving contaminated injecting 
~uipment were promoted. A hierarchy of messages was aimed at various 
injecting drug using audiences. These includ •d: preferably, don't use drugs; if you 
must use, don't inject; if you must inject, don't share; if you can't help sharing, 
clean your needles with bleach (Loxley, Marsh, Westlund and Watson & Kosky, 
1990). To discourage sharing of injecting equipment needle and syringe 
distribution and disposal programs were initiated which entailed tlle 
implementation of needle exchange and outreach programs, the sale of sterile 
injecting equipment through pharmacies and the introduction of needle vending 
machines. Injecting drug users \'.'ere encouraged to clean used injecting equipment 
with the use of bleach, if they were to be re-used. Furthermore drug substitution 
programs were expanded, relaxing the previous strict criteria for entry, to enable 
persons access to oral methadone as a substitute to injection of heroin, thus 
reducing the number of injecting drug users and the consequent hann associated 
with this mode of administration (Wodak, 1990; National Methadone Policy, 
1993). As Cuatt (1989) notes, by educating injecting drug users of the potential 
danger of HIV infection through unsafe practices and making sterile injecting 
equipment widely available and accessible, it was reasonable to assume that 
needle sharing behaviour would decrease. 
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Needle and Syringe Supply 
As a result of the governments' prevention strategies, since 1986 in Australia 
sterile injecting equipment has been made available to injecting drug users. 
Needle exchange programs, outreach vans and vending machines have been 
introduced in locations where there are significant nwnbers of injecting drug users 
(Crofts, 1992; Dodding, 1993?; Dolan, 1989; Loxley et al, 1990; "IV drug users," 
1989). In addition, pharmacists have been encouraged to sell sterile injecting 
equipment to injecting drug users, thereby assuring availability in both 
metropolitan and rural areas. The Pharmacy Guild of Australia and the 
Pharmaceutical Society of Australia supported the strategy but left the decision to 
supply needles and syringes to drug users to the professional judgement and 
discretion of individual pharmacists (Cuatt, 1989; Tsai et al, 1988). 
Western Austrnlian Initiatives 
In Western Australia a harm minimisation policy was adopted and promoted by 
the Health Department of Western Australia and the AIDS Council with the 
hierarchy of messages being promoted to various injecting drug using audiences. 
In late 1986 a decision was made by the Health Department of Western Australia 
to promote the sale of sterile injecting equipment to injecting drug users by 
pharmacists, who were seen to be "accessible, strategically placed, already selling 
needles and syringes to diabetics and had a legitimate role in health care" (Loxley 
et al, 1990, p. 14). 
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Under the joint auspices of the Health Department of Western. Australia and the 
Ph· :maceutical Council the SS5 Kit Pharmacy Program was established in July 
1987 (Kerry, 1994). The SS5 Packs, consisting of a plastic bag containing one 
sterile needle and syringe, a swab, condom, lubricant, a rigid disposal r-<>ntainer 
and an information pamphlet were supplied by the AIDS Bureau free to 
pharmacists, who added four needles and syringes and sold them at • profit By 
1990 56% of metropolitan and 25% of counby pharmacies were participating in 
the program (Swensen, Westlund & Baker, 1992). In July 1992 the Pharmacy 
Fitpack Program replaced the SS5 Kit Pharmacy Program (Kerry, 1994). Fitpacks 
are a specially designed black plastic pack which holds five needles and syringes. 
The packs are designed to provide a safe and convenient method of storing and 
carrying frrst sterile, then used needles which may be locked securely in place and 
the Fitpack disposed of in a public waste disposal bin. The Pharmacy Fitpack 
Program was initially subsidised by the Health Department of Western Australia, 
but since 1992 it has been a commercial operation for pharmacists who now deal 
with wholesalers directly to replenish their supplies (Kerry, 1994). Figures from 
order forms indicate that approximately 78% of Western Australian pharmacies 
are currently involved in the sale of Fitpacks (Kerry, 1994). 
Thel.aw 
In almost all developed countries legal access to sterile injecting equipment has 
been a primary public health approach to help prevent the transmission of HIV 
among injecting drug users (Des Jarlais & Friedruan, 1992). The most notable 
-.,..,..._,...-------·· 
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exception is the UnitOd States where this strategy has remained highly 
controversial with only a few localities adopting it. Des Jarlais and Friedman 
(1992) note that opponents of legal access to injecting equipment in the United 
States have argued that such a strategy would "not work to reduce H!V 
transmission". would 11 encomage" or "condone" illicit drug use, would "send the 
wrong message" and would "undermine our war on drugs" (p. 45). In New York 
City in particular, proposals for the distribution of clean injecting equipment to 
drug users have provoked vehement opposition (Anderson , 1991). The 
abandonment of a needle exchange trial in New York was due to social and 
politica1 resistance. Even clear evidence from overseas that tlJe provision of 
needles and syringes reduced needle sharing without increasing addiction, "was 
outweighed by the policy's symbolic affront to social order" (Anderson, 1991, p. 
1515). 
In Australia, at the time the policy to supply needles and syringes to persons who 
injected drugs illicitly was first implemented, it was an Aiding and Abening 
offence under the Criminal Code in most States and Territories (Schwartzkoff & 
Watchirs, 1991). Some Slate Governments amended legislation almost 
inunediately to indemnifY pharmacists and needle exchange workers from 
prosecuticm. In other States, incJuding Western Australia, agreements were 
reached bdween State Health Departments, AIDS Councils and the police to 
enable the distribution of sterile injecting equipment, while lobbying for 
legislative change. Western Australia was the last state to have legislation 
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am, Jed to remove legal restrictions from the distribution of needles and 
syringes, although supply has been unofficially condoned and implemented since 
1987. 
As previously discussed, it ·vas still illegal to provide needles and syringes to 
iqjecting drug users in Western Australia at the outset of this research endeavour. 
Legal sanctions were removed, however, when the Poisons Amendment Act 1994 
was proclaimed on May 24, 1994 making it legal in Western Australia, for 
persons gaining the approval of the Commissioner of Health, to prov.Je needles 
and syringes to injecting drug users. A special edition of the Western Australian 
Government Gazette on May 26, 1994 outlined the regulations, duties and 
requirements of persons engaged in the provision of needles and syringes and 
included a copy of the application for approval required to conduct such 
programmes (Poisons Amendment Regulations 1994 ). Copies of the Poisons 
Amendment Act 1994, the special edition of the Government Gazette and a 
Poisons Act 1964 Form 14, Application for approval of needle and syringe 
program (see Appendix A), were pnsted to all Western Australian community 
pharmacists and needle exchange operators (K. Kerry, personal commurtication, 
October 6, 1994 ). Concerns were expressed by some pharmacists in relation to 
having to gain approval for an activity they had been involved in for some time in 
the public interest, and the fact that they were expected to submit yearly reports 
(K. Kerry, personal communication, August 20, 1994). In light of the concerns 
exoressed, the Pharmaceutical Council of Western Australia negotiated with the 
32 
government to enable the Council to gain a blanket approval for all pharmacists. 
On September 5, 1994 the Pharmaceutical Services Branch of the Health 
Department of Western Australia granted permission to the Pharmaceutical 
Council to coordinate the program for blanket approval for pharmacists to sell 
Fitpacks only for a term of 12 months (B. Fry, personal communication, January 
19, 1995). The sale of needles and syringes to injecting drug users in other forms 
required the pharmacists to personally apply for approval to do so. 
Although supplying needles and syringes to injecting drug users was illegal 
(although condoned) in Western Australia until May 1994 an increasing number 
of pharmacists were providing them. Between 1990, when 44% of pharmacists 
overall were involved in the SS5 Pack Program (Swensen et al, 1992) and 1994 a 
further 34% had adopted the practice. 1t is apparent that the majority of 
pharmacists were not deterred by the legislation but some still did not supply and 
the reasons for this were not known. Neither was there any infonnation available 
concerning the reasons for the change in pharmacy policy of those who have 
adopted the practice. 
Deterrence Theoty 
Deterrence theory is based on the premise that 11the more the individual perceives 
legaJ sanctions as certain, swift and/or severe, the greater is the perceived cost of 
crime and thus the probability of deterrence" (Williarns & Hawkins, 1986, p. 
547). According to Home! (1988) certainty of punishment is historically 
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regarded as the most important of these variables rather than the mere existenCe 
of legal sanctions. Home! explains that the argument for deterrence as a tool for 
social control is based on the premise that the behaviour of humans can be 
modified by making them fearful of the consequences of committing illegal acts. 
In the words ofGibbs (cited in Home!, 1988): "Deterrence can be thought of as 
the omission of an act as a response to a perceived risk and fear of punishment 
for controry behaviour" (p. 22). 
The classic example of deterrence theory most often quoted is that of the 
effectiveness of Random Breath Testing (RBT) in New South Wales where there 
is a high probability of drivers being stopped and breathalysed and penalties for 
drink drivers are certain, swift and severe (Home!, 1988). A more recent example 
of the application of deterrence theory is reported by Woods ( 1995) and relates to 
the sale of tobacco products to persons under 18 years of age in Western 
Australia Although being illegal since 1917 the activity was widespread, penalties 
were small ($4 for a first offence) and no prosecutions were recorded. The 
passing of the Tobacco Control Act 1990 increased penalties for sale of tobacco 
products to persons under 18 to $5,000 for individuals and $20,000 for corporate 
bodies for a first offence. A study conducted 14 months after the law came into 
effect found that this alone was not enough to deter the majority (89%) of tobacco 
retailers (cited in Wood, 1995). Based on deterrence theory principles the Health 
Department of Western Australia devised and applied "the 3 Ps of prosecution, 
publicity ond persuasion" (Wood, 1995, p. 8). This resulted in mnch publicised 
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prosecutions with penalties rangUig consistently between $500 and $1 ,000 plus 
court costs. Within two years a further study showed that the percentage of 
retailers prepared to sell tobacco products to minors had dropped dramatically by 
6lo/oto 28%. 
Although the sale of needles and syringes to injecting drug users was illegal in 
Western Australia there was an unwritten agreement that it would not be enforced. 
It was considered useful to use this study to determine whether the legal status in 
this context had any effect on needle and syringe supply. If deterrence theory is 
correct then mere legislation would not deter. 
AUitudes tn lnjeding Drug Users 
According to Wodak (!992) the prevailing public image of drug users in the mid 
1980s was of "psychopathic demons" (p. 557). However, within a few years this 
image had modified with increasing attention directed to the complex nature of 
drug use and the deficiencies in the treatment system, so that rather than being 
seen as "archetypal villains" injecting drug users were seen, in part, as victims. 
As Wodak points out "without this change in image, it would not have been 
possible to generate public support for some of the more controversial measures 
required to control HIV infection in this risk group" (p. 557). 
While Wodak (!992) contends that injecting drug users "are still demonised to 
some extent in Australia" (p. 557) MacCarthey (1994) claims that discrimination 
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ag•ainst injecting drug users is widespread. In an article in the National AIDS 
Bulletin MacCarthey (1994) asserts that "the concept of discrimination is based on 
fairness .... [the principle of which) ... does not apply to groups that are perceived 
to make lifestyle choices" (p. 32). Therefore society generally justifies 
discriminating against injecting drug users as injecting drug use is seen only as a 
lifestyle choice and, at some time in an injector's life, a decision to inject was 
made. Other factors at play that may help explain the extent 0f discrimination 
against injecting drug users are listed by MacCarthey as: the illegality of the 
drugs and most associated behaviours; injectors being considered criminals unlike 
other law breakers who may speed, litter, cheat on taxes etc; views of injecting 
drug users coming more from moralistic and often incorrect information rather 
than from accurate research/facts; and negative and emotive media portrayal of 
injecting drug users. According to MacCarthey, one of ways that discrimination 
manifests itself is in the poor response injecting drug users generally experience 
to a wide range of services. 
In a British study of general practitioners Abed and Neira-Munoz (1990) found 
that the majority of general practitioners believed that drug users were deceitful, 
unreliable and uncooperative patients, that their problems were of their own 
making and that drug dependence was not a medical problem. On the other hand, 
only about one third of general practitioners saw drug dependence as morally 
wrong. Abed and Neira-Munoz (1990) stressed that although their study, and that 
ofGianz (cited in Abed & Neira-Munoz, 1990), highlighted definite negative 
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attitudes towards drug dependents some positive attitudes were also demonstrated, 
particularly by younger general practitioners who were more prepared to take an 
active part in their management. 
Although MacCarthey (1994) claims widespread discrimination of injecting drug 
users in Australia it appears that Wodak's (1992) assertions of a moderation in 
image may have occurred among the pharmacists' fraternity, considering the 
adoption of the governments' harm reduction initiatives by pharmacists. However, 
it is not known what the attitudes of pharmacists in Western Australia are towards 
injecting drug users, or to what extent this impacts on the supply of sterile 
injecting equipment to injecting drug users. 
Previous Australian Studies 
A literature search has located nine previous Australian studies, including two 
from Western Australia, relating to the supply of needles and syringes by 
pharmacists to injecting drug users. The purpose of the studies differed slightly 
and focused on a number of research questions ranging from attitudes of 
pharmacists regarding the provision of needles and syringes to injecting drug 
users to evaluations of the programs that supplied packs of needles and syringes. 
Both Western Australian studies were evaluations of the needle-pack program 
current at the time. A variety of sampling procedures and data collection methods 
were used. A summary of the studies and their characteristics are outlined in 
Table I with the main findings presented in the following section. 
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Table 1 
Review of Australian Stu!Jies 
Response Selling 
Author Year State Area Sample Rate Method Practice Research Question 
Guastclla. R. &. Roller, L. 1986 Victoria Me!ro Random Sample 9.5"/o Interview Schedule C/S 36% Attitudes to selling N&S to IDUs. 
Victorian College ofPhllnltacy N=38 NJS 64% 
Jennings, G. 1987 Victoria 10 Rural All Phannacists 96.50% Telephone Interview CIS 63% Attitudes on AIDS and lbe 
Health Promotions, Victoria Cities N=85 Prc·postcd schedule NIS 32% availability ofN&s to IDUs. 
PIS 5% 
Monash Medical School 1987 Victoria Motro Systematic Sample 86.40% Interview Schedule CIS 45% Attitudes and practices In relation 
Melbourne. Victoria N=:96 NIS 46% to the sale ofN&S to IDUs. 
PIS ..... 
Tsai, Goh, Wcbcck & Mullins 1987 NSW Metro& Stratified Random 96% Telephone Qucstiormairc Attituries towards existing N&S 
Epidemiology, Health Dcpl NSW Country Sample N=llO distribution and needle cxclmngc 
progrmffi and role in educating dients. 
Mullins. R. M. 1989 Victoria Motro& All Victorian 38% Mail Questiormaire CIS 29% Phannacists willingness to participate 
HcaiUt Promotions Unit Country Community NIS 26% in initiatives to increase saJes. 
Health Dept. Victoria Phannacists PIS 14% 
CUatt, L. 1989 Tasmania Whole Pharmacy Guild 48% Mail Questionnaire CIS 32% Attitudes and practices of pharmacists 
Tasmanian AIDS Council slate members N"" 150 NJS 68% regarding lhc sale ofN&s to IDUs. 
Swcnsen, Wcstlund & Baker 1990 WA Whole Study of order fonns for CIS 44% Evaluation ofSS5 Pack Program. 
Health Department ofWA 
""' 
the SS5 Pack Metro 56% 
Country25% 
MSJ Keyes Young 1991 NSW Metro & PU!posivc Sample 58% Mail Questionnaire Evaluation of the Fitpack Program. 
NSW AIDS Bureau Cournry N=80 
Greig. R. 1992 WA Purposive Sample 97.40% Telephone Interview CIS 86% Evaluation of the Fitpack Progrwn 
WA AIDS Bureau N=114 NIS 10% 
w PIS 5% 00 
Note. C/S =CUrrent sellers; PIS::: past sellers; N/S =never sold; N&S =needles am syringes; ID Us::: injecting drug users. 
Phannacisls' Pereeptions of the Seriousness of IiivtAIDS 
Pnblic health. 
Indications are that the majority of Australian pharmacists recognise the serious 
implicaticns of HIV/AIDS. In a Melbourne study, when asked to list the three 
most important health problems facing Australia, pharmacists gave an 
overwhelming priority to AIDS, which accounted for 51% of first mentions and 
26% of all mentions (Monash Medical School, 1988). The researchers commented 
that even allowing for thf; respondents' awareness that AIDS was the main topic 
of the study, it was clear Melbourne pharmacists did not underestimate the gravity 
of the HIV epidemic. However, results from Jennings (1987) study revealed that 
fewer Victorian rnral pharmacists ( 46.4%) saw AIDS as a major public health 
issue in Victoria A similar result was elicited by Cuatt (1989) in Tasmania where 
43% of pharmacists perceived AIDS to be a serious or reasonably serious public 
health risk. 
lnjectim: dl!ll: use ... 
A higher proportion of pharmacists believed injecting drug users to be at greater 
risk of AIDS than the general population. In Tasmania 89% of pharmacists 
believed that AIDS was a very serious or reasonably serious health risk for 
.intravenous drug users in that state. Two thirds (65.8%) of rural Victorian 
pharmacists saw the risk of spreading AIDS through injecting drug use as high to 
very high and 79% saw the connection between needle sharing and the spread of 
AIDS as very strong (Jennings, 1988). Figures from the Melbourne study also 
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indicated 56% of phannacists thought there was a high risk of HN infection 
s;m:ading extensively among injecting drug users from whom, phannacists 
believed, the potential for further spread to the general population was moderate 
to very higb (Monash Medieal School, 1987). 
Phannacists' role in relation 1D AIDS. 
In Victoria 82% of phannacists believed they had a special role ill relati•>n to the 
control of AIDS (Jemtings, 1987; Monash Medieal School, 1988). The main role 
they saw for themselves was the provision of advice and counselling. Dispensing 
literature on AIDS and drug rehabilitation was seen as appropriate in many 
country phannacies and 82.9% of phannacists were prepared to do so (Jemtings, 
1987). The other most frequently nominated roles were the sale of needles and 
syringes to injecting drug user.; and the sale of condoms. 
Snmmwy. 
It is apparent from these studies, which were all conducted soon after the 
initiatives to provide needles and syringes were implemented, that pharmacists 
were well infonned of the seriousness of HIV, especially to injecting drug users. 
The majority of phannacists also believe that they have a special role to play in 
relation to the control of AIDS. 
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Needle St•wly Pmctices 
An increasing number of pharmacists throughout Australia have taken up the 
challenge to help prevent the spread of blood-home disease by adopting the harm 
reduction strategy of supplying sterile injeeting equipment to injecting drug users. 
This trend was first noted in New South Wales by Tsai, Gob, Webeck and 
Mullins (1987) who found that there was a significant favourable shift in 
pharmacists' attitudes towards selling needles and syringes to injecting drug users 
in the four months between the public launch of the Anti-AIDS Kit in Decemoer 
1986 and the survey conducted in March 1987, from 14.1% before to 57.6% after 
the launch. While the survey results revealed that over half the pharmacists 
supported the needle dis1ribution program only 11.9% actually sold Anti-AIDS 
Kits at the time. The other 45. 7%, however, were willing to supply but had not 
been approached. The majority of pharmacists in New South Wales now supply 
sterile injecting equipment, and many are also involved in needle exchange. One 
of the factors that probably influenced the early and rapid adoption of the sale of 
needles and syringes in that state was that, in 1985, the New South Wales 
Government amended legislation thereby removing the sanctions of seiiing or 
possessing needles and syringes. 
Figures from Victoria indicate that although needle and syringe supply started 
well, it increased at a slower pace. For example an early study by Guastella and 
Roller ( 1986) found that of 36 randomly selected Melbourne pharmacists 36% 
had sold needles and syringes to injecting drug users and a further 11% intended 
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to. In comparison, four years later in 1990 Mullins (1990) reported that 59% of 
pharmacists were current sellers, representing only a 12% increase in that time, 
although 14% of pharmacists in this study were past sellers. Mullins' study 
however only had a 38o/ response rate so the representativeness of the sample 
comes into question. In addition, it could he argued that another factor that may 
effect the comparison between the two studies is that the first study was of 
metropolitan pharmacists only, while Mullir.s surveyed all Victorian pharmacists. 
However the fmdings of two other studies in 1987 would not support this 
argument as the Monash Medical School's ( 1987) survey of metropolitan 
pharmacists found that 45% were current sellers, compared to Jennings (1987) 
fmdings that 63% of pharmacists in 10 country cities were current sellers and a 
further 11% intended selling. 
The Tasmanian experience differed again and pharmacists were much slower in 
adopting the practice of selling needles and syringes to injecting drug users. The 
results of Cuatt's (1989) study indicated that by 1989, only 32% were selling 
steriie injecting equipment to the general public. At that time, however, it was still 
an offence in Tasmania to possess a needle and syringe if it was to be used to 
administer an illegal substance, a factor which affected 31% of the non-sellers 
who responded that a change in the legislation would encourage them to supply. 
In addition, the Tasmanian State government did not support the strategy to the 
same extent as other state governments at that time. 
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In Western Australia evidence shows that the number of phatmacists selling 
needles and syringes has increased despite the fonner legal ssnctions. For 
instance, in 1988 there were 72 outlets selling Fitpaclcs, which increased to 196 
by 1990,44% of the total Western Australian pharmacists (Swensen, Westlund & 
Baker, I 990 ). Of these, there were 169 metropolitan and 25 country phannacists, 
a participation of 56% of metropolitan and 25% of country pbannacists. In 1994 
Kerry (1994) reported !ha~ based on infonnation from order forms, approximately 
78% of pbannacists were selling Fitpacks, a 34% increase since the earlier study. 
As these figures are only related to the sale of Fitpacks and don't include needles 
and syringes sold in other fonns it is possible that an even higher percentage of 
phannacists are involved in the provisim1 of needles and syringes to injecting 
drug users in Western Australia This was the case in Greig's (1992) earlier 
survey of pharmacists where 83% of pharmacists sold Fitpacks and a further 3% 
sold only single needles and syringes to injecting drug users. It is interesting to 
note that accvrding to Greig's study, 83% of pharmacists were selling Fitpacks in 
1992 compared with the 78% quoted by Kerry in 1994. Considering the 
proportion of current sellers in Western Australia it i!: apparent that the legislation 
did not deter the majority of pharmacists from adopting the harm reduction 
strategy of supplying needles and syringes to injecting drug users. It must be 
remembered however, that the practice was officially condoned. 
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Difficulties ExPerienced by Pbannacisls 
The most common factor cited for not selling needles and syringes was concern 
about injecting drug users frequenting the pharmacy (Tsai et al, 1988; Cuatt, 
1989; Monash Medical School, 1987; Guastella & Roller; Greig, 1992). For 
example in the early days of needle and syringe supply Guastella and Roller 
(1986) found that for 55% of pharmacists who said they did not intend to sell 
needles and syringes to injecting drug useiS the commonest reason given was that 
they did not want to attract 'this type of person'. Some felt they would be 
overcome by 'undesirable's. Tsai, Gob Webeck and Mullins (1987) also found that 
the majority of pharmacists who said they would not sell Anti AIDs Kits were 
wonied about the anti-social behaviour of injecting drug users. More recently, of 
Western Australian pharmacists who had never sold 54% did not like the clients 
and feared assault (Greig, 1992). More specific reasons given include increased 
security risk and shoplifting (Tsai et al, 1988) and drug abusers being aggressive 
and unpleasant - cited by 94% of nonsellers (Monash Medical School, 1987). 
However, the Monash Medical School (1987) claimed that fear from the 
behaviour of injecting drug users was, t.o a large extent, was not borne out by the 
experience of the pharmacies that did sell. Other factors cited for not selling 
included moral and ethical reasons, belief that it would increase drug addiction, 
adverse effects on other customers, complaints from other customers and legal 
uncertainty in one case already mentioned. 
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An average of 7.9% of past sellers were identified in four surveys, ranging from 
' 4.5% to 14% (Greig, 1992; Jennings, !987; Monash Medical School, 1987; 
Mullins, 1990). Past sellers main reasons for no longer participating included fear 
and/or experience of threat and/or assault (Jennings, 1987; Greig, 1992) 
undesirable or disruptive customers (Jennings, 1987), the unsavoury nature of the 
practice and harmful effects on the business (Monash Medical School, 1987). 
There is little information about problems experienced by current sellers. MSJ 
Keys Young, however reported that 25% of current sellers did not like the 
customers that Fitpacks bring. In addition, the study conducted by the Monash 
Medical School (1987), just before the legislative change to permit needle and 
syringe supply, found that the main factor troubling current sellers was 
uncertainty about the legal and ethical principles of the practice. 
Summruy 
From the studies reviewed the main difficulty for pharmacists, regardless of 
supply practice, concerns having injecting drug users in their pharmacy and the 
associated problems. However, the legal ramifications was a consideration in 
some instances where it was still an offence to supply needles and syringes to 
injecting drug users. 
Review Summa:ry 
This chapter has presented the background to the provision of needles and 
syringes to injecting d.-ug users by pharmacists. It reveals why it is important that 
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these initiatives be continued and identifies issues that may impact on supply 
practice. The review of previous studies has additionally revealed attitudes, 
practices and experiences of pharmacists regarding these issues. 
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CHAPfER THREE 
Method 
Omanisatiooal Supporj 
In conducting this research endeavour every effort was made to ensure its smooth 
running, embracing ethical principles to legitimize the study and enbaoce the 
cooperation of phannacists, ever mindful that a good response would add weight 
and credibility to the findings. An important aspect of this approach was to elicit 
the support of the phannacists' professional organisations. 
In Western Australia two professional organisations with which pharmacists are 
associated are The Pharmaceutical Council of Western Australia and The 
Pharmacy Guild of Australia. The Pharmaceutical Council, which is the 
administrative body of the Pharmaceutical Society of Australia in Western 
Australia, is the organisation with which all community pharmacists are registered. 
The Council also administers the phannacists' trainee programme and provides 
continuing education for phannacists (Megan Williamson, personal 
communication, September 14, 1994). The Pharmacy Guild, of which 95% of 
Western Australian community phannacists are members, is an employee 
organisation registered with the Federal Industrial Commission, and aims to 
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"represent the interests of members in industrial matters and to further and protect 
the interests of, and generally do anything which may be considered beneficial 
for, its members" (Nick Geronimos, personal c'Jmraunication, September 14, 
1994). Because of the involvement of these organisations both were approached 
prior to the commencement of the study in order to inform them of the proposed 
research and enlist their support 
Consultation took place with both organisations during the development of the 
pilot and final questionnaires. Both organisations endorsed the study and have 
expressed their interest in receiving the final results. In addition a Survey 
Certificate was issued by The Pharmacy Guild of Australia (see Appendix B) with 
a number and rating to be conveyed to pharmacists as an indication of the Guil<fs 
approval of the study. Approval of the pharmacists' professional bodies was 
sought out of courtesy and for the sake of a smoothly executed study (Gay, 1987, 
p. 102). 
Researeb Design 
A descriptive research design was employed "to answer questions concerning the 
current status of the subjects of the study" (Gay, 1992, p. 251), utilising the self-
report mail survey method for the collection of data. According to lsaac and 
Michael (1971) this is an appropriate method to determine what others are doing 
in si~ilar situations, make comparisons. and benefit from their experience in 
making future plans and decisions. As the study included pharmacists throughout 
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Western Australia a mail survey was chosen because of its usefulness in gathering 
data from persons in "widely scattered locations covering a large geographical 
area" (Clover & Balsley, 1979, p. 95). 
Sample of Subjec!s 
Based upon information provided by The Pharmaceutical Council of Western 
Australia there are 466 registered community pharmacies in Western Australia 
From the list of these pharmacies provided by the Council a stratified random 
sample (N ~ 130) was selected on the basis of metropolitan and country location. 
Metropolitan pharmacies were distinguished as those within the Perth local 
telephone call range. Of the 130 subjects chosen 85 (65%) metropolitan and 45 
(35%) rural pharmacists were targeted. This did not represent an equal proportion 
of metropolitan and country pharmacists, which was 74% and 26% respectively. 
There were two reasons for altering the ratio of pharmacists for the study. Firstly, 
based on the true ratio, only 34 country pharmacists would be targeted and, 
considering the average response rate was 48% in simiJar AustraJian studies 
utilising self administered questionnaires (Mullins, 1990; Cuatt, 1991; MSJ Keyes 
Young, 1991 ), a return of only 16 questionnaires could reasonably be expected. 
With the further division into sellers and non-so:llers, bearing in mind Kerry's 
(1994) claim that The Pharmacy Fitpack Program currently operated from 78% of 
pharmacies across Western Australia, the numbers could be reduced to cells of 
approximately 12 sellers and 4 non-sellers which would not give significant power 
for the analysis. Secondly, previous formal studies regarding the issue of needle 
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and syringe supply have not surveyed country phannacists in Western Australia, 
and it was thought that by increasing the ratio of country pharmacists in this 
research this deficiency could be redressed. 
Using a standardised telephone inlerview format (see Appendix C) the phannacist 
in whose name the pharmacy was registered was approached to complete the self 
administered questionnaire. It was found in some cases however, that a manager 
rao the pharmacy, so in these instances the manager was asked to participate. In 
three cases a re-draw was made for the following reasons: 
I. One pharmacy did not answer the telephone after being called three 
times on each of four successive days. Two further calls on two days of the 
following week also failed to elicit a response. 
2. Two pharmacies drawn from nearby country towns were owned and run 
by the same pharmacist who travelled between them, each pharmacy having his 
services at certain times. Needles and syringes were not sold at either pharmacy 
due to there being no demand. It was felt that it would serve no purpose to have 
the phannacist complete two questionnaires. 
3. One pharmacist was on holidays for four months and a locum was 
running the pharmacy. As infonnation sought was related to the attitudes and 
practices of the pharmacist who owned or managed the pharmacy and who was 
involved in making policy decisions, a re~draw was made. 
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Questionnaires 
Two separate questionnaires, relevant to the current selling practice of 
pharmacists, were specifically desigoed for the study (see Appendixes D and E). 
The content of both questionnaires was the same except for the sections 
concerning current selling practices. Adoption of this strategy minimised the need 
for numerous speci.J instructions and decreased the length of the questionnaires. 
This had the benefit of ease of self-completion by respondents with a view to 
increasing the response rate. 
Pilot of the Questionnaires 
Initially the questionnaires were piloted by I 4 persons including nine health 
professionals, two alcohol <:ounsellors, two general practitioners and three 
phannacists. This represented 11professionals who understand the study's purpose, 
... potential 'users' of the data [and] people ... from the population to be surveyed", 
a strategy suggested by Dillman (1978, pp. I56-!57). Persons other than 
pharmacists were asked to adopt the role of seller, non-seller or past seller as 
indicated on the top of the questionnaire so that an sections of the questionnaires 
were tested. A brief statement (see Appendix F), outlinmg the study's purpose and 
the procedure to be undertaken in conducting the survey was included, with a 
request for comments on any difficulties or ambiguities found in the 
questionnaire, suggestions for improvement and for the time it took to complete. 
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All respondents agreed that the format of the questionnaires was appropriate, 
unambiguous and the questions easy to complete. The average time for 
completion was 17 minutes, ranging from seven minutes to 40 minutes. There 
were seven suggestions for inclusion of extra question categories, each of which 
was given careful consideration resulting in one fmally being adopted. This was 
the inclusion of "vending machines" in Item 8 which asked where pharmacists 
think nee.dles and syringes should be obtained. In addition, the suggestion that the 
words "the prevention of' be included in Item 7 was also adopted to now read, 
"What role do you think pbannaci'ts should play in relation to the prevention of 
HIV and Hepatitis"? 
Content of Questionnaires 
The questionnaires were divided into a number of domains including public 
health, needle and syringe distribution, current practices, legislation, attitudes to 
injecting drug use and injecting drug users, and demographic details. Ordering of 
the questions was based on suggestions by Dillman (1978). This included piacing 
questions which respondents were most likely to see as socially important or 
useful first and the least useful last; grouping questions of similar content 
together, and within content areas, by type of question; and taking advantage of 
cognitive ties that respondents were most likely to make among groups of 
questions. 
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Public health. 
The first set of questions related to pharmacists' beliefs about public health in 
relation to HIV, hepatitis C and injecting drug use. This section was included in 
an effort to gauge phannacists' perception of the significance of these issues in 
Western Australia and what they believe their role to be in relation to the 
prevention of HIV and hepatitis C. 
Needle and syringe distribution. 
To detennine phannacists beliefs concerning needle and syringe distribution this 
section included questions concerning where (e.g., hospitals, drug treatment 
agencies, phannacies), and how (e.g., buy, exchange) injecting drug users should 
obtain new equipment. Other questions related to phannacy policy regarding the 
sale of needles and syringes to injecting drug users and whether phannacists 
supported the govenunent's harm minimisation strategy concerning needle and 
syringe supply. Also included in this domain was a question regarding training in 
an attempt to ascertain to what extent pharmacists have had training regarding the 
supply of injecting equipment to illicit drug users, and to identifY whether there 
was a need in this area. 
Current practices. 
This domain focused on pharm;,tcists' practices in relation to the supply of needles 
and syringes to injecting drug users in the pharmacy in which they were currently 
located. As mentioned earlier, questions in this domain differed for pharmacists 
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who do and do not sell needles and syringes. As this section included some 
potentially sensitive items it was placed towards the centre of the questionnaire 
with the more sensitive items embedded within other items (Dillman, 1978). 
For the pharmacists who do supply needles and syringes to injecting drug users, 
items included when they commenced supply; factors influencing the decision to 
supply; in what form they were supplied (e.g. Fitpacks, single syringes, etc); 
approximate quantity; and cost to the customer. This domain was also concerned 
with problems experienced in the pharmacy concerning sale of needles and 
syringes and the influence this had on selling practice. 
For the non-sellers this domain included questions concerning supply of needles 
and syringes to persons other than illicit drug users, whether needles and syringes 
had been sold to injecting drog users in the past and future intentions regarding 
supply of injecting equipment. Reasons for not supplying were determined and 
problems experienced in the pharmacy concerning irtiecting drug users and the 
influence on selling practices were identified. To conclude this domain both 
questionnaires included a question concerning the dispensing of methadone to see 
whether differences e>:ist between sellers and non-sellers. 
l,.eJ:islation. 
With the recent change in legislation enabling pharmacists and health care 
workers to legally supply needles and syringes to irtiecting drug users this domain 
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was included to detennine phannucists' knowledge of the current legal status of 
supply, and its effect on selling practice. In addition, it aimed to indicate the 
deterrent eftect of the legal status of needle and syringe supply before the cbange. 
Attitudes to injectin: drug use and injecting drug useJS. 
In order to gauge phannacists' attitudes toward injecting drug users this domain 
was included utilising questions from an instrument devised by Ross and Darke 
(1992), the Attitudes Towards Injecting Drug Users Scale (AIDUS). For 
convenience and to contain the Jength of the questionnaire, ten questions were 
selected from the 50 item scale. The items were selected based firstly, on their 
having obtained a correlation co-efficient in the moderate to strong range when 
tested by Ross and Darke for test-retest reliability, and secondly, on their 
perceived appropriateness. As previously discussed attitudes to drug users can 
influence the outcome of treatment and by ascertaining pharmacists' attitudes 
towards injecting drug use and injecting drug users it could give some clue as to 
whether this affects supply practices. 
Demoeraphic details. 
Contrary to the current convention (Tony Fetherstonhaugh, personal 
communication, April 6, I994), de;nographic details were placed at the end of the 
questionnaire. As Dillman (I978) points out, it has often been believed that 
placing this section at the beginning results in fewer nonresponses to these 
crucially important items and that they act as icebreakers giving respondents time 
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to settle. However Gay (1992), Babbie (1986) and Dillman (1978) agree !bat in a 
mail questionnaire demographks should be placed at the eod because there is no 
need for icebreakers as there is no interviewer present to generate nervousness. In 
addition, according to Dillman (1978) experience shows that placing these 
personal details at the end of a mail questionnaire does not lead to nonresponse, 
and in his opinion this may be because respondents view the filling out of the 
earlier pages of the questionnaire as an investment and unless they fiU out the 
personal details the investment is lost 
For the demographic section of the current study items included personal details 
of pharmacists concerning year of graduation, length of time working in the 
profession, time in the current pharmacy, age and gender. Details of the pharmacy 
were also sought including staff numbers, location, opening hours, customer 
groups and postcode. 
To conclude the questionnaire pharmacists were invited to add further comments 
on the issues in the questionnaire or suggested strategies that might be useful for 
pharmacists in dealing with injecting drug users. Finally pharmacists were asked 
to indicate whether they required a summary of the results. 
Reliability aod Validity of the Questionnaires 
The questionnaires were designed using questions and adaptations from previous 
similar Australian studies (Cuatt, 1989; Jennings, 1987; The Monash Medical 
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School, 1987; Tsai et al., 1988;) and some newly developed questions where 
others were not av&lable to elicit the infonruttion required. The section 
concerning attitudes to drug use and drug usero were selected from a 
questionnaire designed 1111d tested by Ross and Darke (1992). 
The internal consisteocy of the scale to measure attitudes to injecting drug use 
and injecting drug users was tested on the results with Chronbach's coefficient 
alpha of .68 indicating that the scale was moderately reliable. While no other 
reliability and validity measures were undertaken, the questionnaire was piloted 
and was examined and approved by the Phannaceutical Council of Western 
Australia and The Pharmacy Guild of Australia. 
Initial Telephone Contact 
Using a standardised format (see Appendix C), as previously mentioned, 
telephone calls were made to selected phannacists to infonn them of the study 
and ask them to participate. The importance and value of their participation was 
expressed and an assurance of confidentiality of infonnation was given. At this 
timo they were also advised that the Pharmaceutical Council of Western Australia 
and the Phannacy Guild of Australia approved of the study. In addition, 
pharmacists' current practice concerning the supply of needles and syringes to 
injecting drug users was determined. This had two purposes. Firstly, to establish 
which questionnaire to forward to. those willing to participate, and secondly, to 
ascertain the current supply practice of non-respondents. The calls were made 
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over a period of four days in the first week of July, 1994. Details of each call 
were entered onto a prepared form (see Appendix G) to record the outcome. 
Mail Out 
Once the pharmacists willing to participate were identified (n ~ 129) and their 
current supply practice determined, a package of material was posted to them. 
This consisted of the relevant questionnaire, the cover letter (see Appendix H) and 
a return addressed reply paid envelope. Each questionnaire was numbered for 
identification purposes in order to implement follow-up procedures if required. 
Cover leUer-
The cover letter (see Appendix H) outlined the pUipOse and significance of the 
study, the size of the sample and the method of sampling. The imponance of the 
pharmacist's valuable input was emphasised with an assurance of confidentiality. 
Instructions for completion and return of the questionnaire were included adding 
that a summaty of the findings would be available on request. Teiophone numbers 
were provided for further information if required and pharmacists were thanked 
for their participation. 
When preparing the mail out, the greeting, the return by date (which was 
designated as approximately two weeks from the date of postage), and the 
Pharmacy Guild of Australia's survey approval number and rating were 
handwritten on the cover letter. 
58 
Follow-up Telephone Calls 
Using standard fonnats (see Appendixes I and J) two follow-up telephone calls 
were made to non~respondents, the first approximately two weeks after the due 
date and the second a further three weeks later. A total of 12 replacement 
questionnaires were forwarded to subjects, six after each follow~up. 
Uttem of Appreciation 
Letters of appreciation were sent to all respondents infonning them of the 
overwhelming response to the study and thanking them for their participation. 
Details of the expected availability of the results were given. There was a slight 
difference in the wording of the letters dependent upon whether the phannacists 
required a personal copy of the results (see Appendixes K and L). 
Similar letters were also sent to the Director of the National Services Division of 
the Phannacy Guild of Australia in Victoria, the President of the Pharmacy Guild 
of Australia in Western Australia and the Registrar of the Phannaceutical Council 
of Western Australia (see Appendixes M, N and 0). In these letters, after 
informing them of the cooperation of phannacists in responding to the study, and 
the excellent response rate, appreciation was expressed for the assistance given by 
the organisation. The expected availability of the results was also provided. 
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Response Rate 
Response ID the Initial Telephone Call 
Of the sample of 130 pharmacists telephoned 129 (99.2%) consented to receiving 
a questionnaire. The one refusal was from a country pharmacist who was happy 
to provide the information that he sells Fitpacks but added that he does not fill in 
questionnaires. One pharmacist agreed to have a questionnaire although he 
claimed he did not usually participate in surveys, and probably would not 
complete and return it; it depended on the content. He also declined to divulge his 
current selling practice except to say that it changed over time. dependent on the 
Pharmaceutical Council's recommendation. On these grounds he was forwarded a 
seUer's questionnaire. A number of other issues were raised by pharmacists and 
these included: one pharmacist advised that he would return the questionnaire 
providing the questions were not too sensitive; three pharmacists expressed 
concern that the findings of the research may misrepresent pharmacists' views or 
misconstrue their feelings about the issues; and the importance of the inclusion of 
the approval number from the Pharmacy Guild was expressed by one pharmacist. 
In the main, pharmacists reflected a positive attitude towards the study and a 
willingness to comply. 
Response to the Study 
From the 129 questionnaires distributed a total of 117 were returned representing 
a response rate of 90%. Of these 90 (69'/o) were returned within the first two 
weeks, 15 (12%) after the first follow-up telephone call and 12 (9%) after the 
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final follow-up call. Of the non-respondents (n ~ 12) two claimed to have 
returned the questionnaire but these were not received; there were three refusals at 
follow-up from pharmacists who either found the questionnaire too complicated 
(!! = I) or too sensitive(!!~ 2); and while the other seven agreed to return the 
questionnaire at the initial telephone call and also agreed at each of the two 
follow-up calls, they failed to respond. Of the 117 questionnaires returned, 75 
were from metropolitan and 42 were from country pharmacists. Of these 115 were 
included in the analysis, one being discarded due to non-completion and one 
arriving too late for inclusion. The usable questionnaires represented 88.46% of 
the sample of 130 pharmacists approached to participate in the study. For a 
detailed depiction of the response and follow-up see Appendix P. 
According to Babbie (1986) a mail survey response rate of 60% is good, with 
70% considered very good. However Dillman (1978) claims that with his Total 
Design Method, for homogenous groups response rates can be expected to exceed 
85% for mail surveys. The response rate in the present study is considered 
particularly good, especially when compared to similar Australian mail surveys. 
For instance, this included response rates of 37.8% for Mullin's (1990) study of 
all Victorian community pharmacists, 48% for Cuatt's (1989) survey of all 
Tasmanian Pharmacy Guild members and 58% for a purposive sample of New 
South Wales pharmacists (MSJ Keys Young, 1991). 
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Edrical Con_sidemtions 
An important ethical consideration of the study was that phannacists be assured 
that the infonnation they provide be confidential. As Ibis study in many ways 
addresses sensitive issues it was important for the pharmacists that their responses 
remain anonymous. This has been addressed by not requiring names on the 
questionnaires, which have been identified only by numbers for follow-up 
purposes. The cover letter explained this procedure to participants and they were 
assured of confidentiality both in the cover letter and the initial telephone calL 
In respect to informed consent the strategy of telephoning the sample of 
phannacists before forwarding the questionnaires gave them the opportunity to 
refuse to participate from the outset. Coercion was not used at any stage and for 
the few phannacists who had concerns about the study it was explained that their 
participation was completely voluntary. 
The other dimension of informed consent gained for the study was that of the 
pharmacists' "gatekeepers" (Homan, 1991, p. 82), the Pharmaceutical Council of 
Western Australia and the Pharmacy Guild of Australia. One possible explanation 
for the high response rate was the fact that approval of both organisations had 
been given for the study. This may have added to the legitimacy and credibility of 
the research and hence the response rate. 
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Dam Analysis 
Although most of the data were precoded, the data from open questions was 
coded later, after which all data were entered into a Microsoft Excel 4 (1992) 
spreadsheet which was then converted onto SPSS for Windows 6 (1993) 
Statistical Package for the Social Sciences for the analysis. 
During the analysis the pharmacies were divided into two groups in respect to 
opening hours (those who opened for nine hours or less per day and those open 
for more than nine hours) in order to detennine those with extended trading 
hours. They were also grouped in respect to days, so that the nurober of days 
open for weekdays and weekend days could be ascertained. These measures were 
taken to detennine whether there were any differences betw-een selling practice in 
terms of trading hours. In addition the positive questions in the Likert scale 
regarding pharmacists' attitudes to injecting drug use and injecting drug users 
were reverse coded so that the point vaJues of the negative and positive responses 
were correctly calculated. As previously mentioned Chronbach's alpha was also 
calculated on the results of this scale to test for internal consistency. 
Frequencies and summary statistics; to discover the mean, standard deviation and 
the range of scores, were caJcu1ated. These were used to describe the 
characteristics of the sample, determine the extent to which pharmacists currentJy 
sell needles and syringes to injecting drug users and determine the factors that 
have influenced changes in supply practices over time. 
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Additionally, calculation was conducted to determine the lilctors that differentiated 
between current sellers and nonsellers. It was found that on the dependent variable 
the groups were of a very uneven size and in some categories there were a very 
small number of responses. This made the use oft tests inappropriate. Moreover, 
some of the chi square analyses were unable to be conducted bc<:ause of 
insufficient cell size. Therefore, as there were a large number of variables likely 
to influence supply practice, to discover the relationships between the variables 
interval variables were left as they were, nominal variables such as practice and 
gender were dummy coded as 0 and l (Hills, 1994) and the independeT!I variables 
were correlated with the dependent variable. Pearson's r was calculated, an alpha 
level of .05 was set and degrees of freedom were set at 1!3. 
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CHAPTER FOUR 
Resul15 
Sample Cbamcteristics 
From the total of 115 useable questionnaires received the pao1icipants in the study 
consisted of 94 males and 21 females. The age range of participants was from 21 
to 64 with an average age of 42.36 (SD = I 0.56). Sixty four percent of 
pharmacists were from the metropolitan region and 36o/o were from the country. 
There was a 43 year span between the time participants registered as pharmacists 
ranging from 1951 to 1994. The average time registered was 20.42 years (SD = 
10.57). All participants had been working as pharmacists since registration with 
the years of experience as a pharmacist ranging from I to 43 years (M = 20.42, 
SD = 10.57). The length of time pharmacists had worked in the present pharmacy 
ranged from 3\1, months to 35 years, an average of 8.41 years (SD = 7.78). 
The most common location of pharmacies was in strip type shopping (37"/o), 
followed by neighbourhood shops (30%), regional shopping centres (14%), 
medical centres (9%), Central Business District (5%) and isolated locations (4%). 
The number of equivalent full time staff employed at pharmacies ranged from 
none to 16 with a mean of 3.4 (SD = 2.99). From a range of options, of which 
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more than one could be selected, respondents were asked to indicate the largest 
customer groups in their pharmacy. The results revealed that elderly people were 
among the largest group of customers for 68% of pharmacists, young families 
followed for 57%, unemployed - 49%, professional/office workers - 20%, passing 
trade- 19%. students - 7% and "alternatives" for 4%. Other customer groups 
mentioned, each by 3% of pharmacists, were fanners, miners and rural workers. 
Details of the opening hours and the percentage of pharmacies open on specific 
days and times are presented in Table 2. Monday, Tuesday, Wednesday and 
Friday hours which were very similar have been averaged and presented together. 
Thursday, Saturday and Sunday hours are presented independently. There was a 
wide range of opening hours of pharmacies with more than half (55%) opening 
Table 2 
Pharmacy openine: hours 
% Phannacies Hours open 
<=9 >9 
Days hours hours Not open Range 
Mon, Tue, Wed & Fri' 45 55 0 3.5 -16 9.87 1.76 
Thursday 28 72 0 3.5- 16 10.59 2.12 
Saturday 76 22 2 3- 16 7.16 3.47 
Sunday ll 17 72 2- 16 9.98 3.72 
Note. Six cases missing, (g = 109) . 
• Mean percentage over the four days. 
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more than nine hours during the weeli except Thursdays with 72%. Only 2% of 
pharmacists did not open at all on Saturday with 22% opening extended hours. A 
total of 28% opened on Sunday with 17% opening for extended hours. The range 
of hours open differs between weekdays and each weekend day with the widest 
range being 2 to 16 how·s on Sundays. Six pbarmacists were not included in this 
analysis because they either did not respond to the question or gave invalid 
answers. 
The Extent tu Which Pharmacists Currently Supply Needles and Syringes 
to Injecting Drug User.1 
The study revealed that of the 115 pharmacists who participated in the study 88% 
(!l ~ 101) currently sell needles and syringes to injecting drug users. The same 
proportion of sellers was achieved at the initial telephone contact when the total 
sample of pharmacists (N ~ 130) were asked whether they currently sold needles 
and syringes to injecting drug users, indicating that there was no difference 
between respondents and nonrespondents in regard to selling practice. Of the 12% 
(!l ~ 14) of nonselling pharmacists 9 were past sellers who had previously sold 
needles and syringes to injecting drug users but had reversed their decision to sell, 
and 5 had never sold. As there was a small proportion ofbotl1 past sellers (8%) 
and pharmacists who had never sold (4%) both were combined into the nonsellers' 
category for the analysis except where specified. 
A breakdown of the figures revealed that 86% (!l ~ 64) of pharmacists from the 
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metropolitan region and 90% (!! = 37) of pharmacists from the country were 
current sellers. Nonsellers included 10 metropolitan (71%) and 4 country (29%) 
phannacists. :rable 3 shows. the supply practice· of participants ·by·lecation with 
metropolitan and country current sellers making up 56% and 32% respectively of 
the total participants in the study. 
Table3 
Suoll:: J!raetice of J!BrticiJ!ants bl: location 
Participants 
Metro Country Total 
Supply Practice n(%) !!(%) n(%) 
Current Sellers 64(56) 37(32) 1 01(88) 
Nonsellers 10(9) 4(3) 14(12) 
Total 74(64) 41(36) 115(100) 
lnjecfing Equipment Sold 
Pharmacists sell sterile injecting equipment in a number of forms and various 
quantities. Ninety seven percent (!! = 98) of current sellers sell Fitpacks, with the 
number sold ranging from 0 to I 00 per week with an average of 17.24 (SD = 
50.62). Single needles and syringes are sold by 22 pharmaci.sts (22%) ranging 
from 0 to 200 per week with a mean of 38.89 (SD = 50.62). Three current sellers 
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(3%) indicated that they sell needles and syringes to injecting drug users in insulin 
packs of 10. Fitpacks are sold at prices ranging between $3.00 and $5.95 with an 
average price of $4.05 each (SO =58 cents). Single needles ranged in price from 
20 cents to $1.00 eaeh (M= 57 cents, SO= 23 cents) with insulin packs between 
$3.95 and $5.00. 
Phanru!cy Policy 
Overall 77% of pharmacists (n = 88) indicated that they had a policy concerning 
the supply of needles and syringes to injecting drug users. This included 75% of 
current sellers (n = 76) and 86% ofnonsellers (n = 12). The main points of the 
policies were coded into categories and are summarised in Table 4. Some 
Table 4 
Main points of pharmacy policy regarding the 
sale ofN&S to ID Us 
Main points 
Sell only Fitpacks 
Sell on request 
Don't sell N&S to ID Us 
Sell without judgement 
Phannacist's authorisation required 
Sell Fitpacks and singles 
Other 
n(%) 
50(43) 
18(16) 
12(10) 
7(6) 
6(5) 
3(3) 
16(14) 
Note. N&S needles and syringes. IDUs =injecting 
drug users. 
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pharmacists listed a number of points to their policies. The most common policy 
was to 'sell Fitpacks only', followed by 'sell on request'. The nonsellers all had 
only the one policy of not selling to injecting drug users. 
Factors That Have Influenced Changes in Supply Pmctice Over Time 
Current SelleB 
Before reporting the factors influencing changes in supply practice, it is 
important to note when pharmacists started to supply needl<:s and syringes to 
injecting drug users. Of the I 0 I pharmacists who sell needles and syringes to 
injecting drug users 8% (!! ~ 8) did not indicate when they began to supply and a 
further 8% did not know or were unsure. As there were 16 missing cases 
percentages were based on the 85 pharmacists who did specifY when supply 
began in their pharmacies. 
The results showed that phannacists began supplying needles and syringes to 
injecting drug users in 1980 (before the advent of AIDS) when 2 pharmacists 
adopted the practice (see Table 5). However, taking up the practice was sporadic 
in the early 1980s. By July 1987, when government initiatives concerning the 
supply of sterile injecting equipment as a preventive measure in the spread of HIV 
were implemented, a further 6 pharmacists were selling to injecting drug users. 
One pharmacist who began supplying in 1987 did not stipulate the month started 
so it is not known whether he or she began supplying before or after the 
government initiatives were implemented. Since 1987 the number of ~uppliers has 
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TableS 
Year pharmacists began supply 
ofN&S to IDUs 
Year 
1980 
1984 
1985 
1987 
1988 
1989 
1990 
1991 
1992 
1993 
1994 • 
Total 
n(%) 
2(2) 
2(2) 
3(4) 
5(6) 
9(11) 
11(13) 
16(19) 
9(11) 
16(19) 
9(11) 
3(4) 
85(102)b 
Note. Only 85 valid answers 
received for this variable. 
'To July 1994. bPercentages do not 
add to 100 due to rounding. 
been steadily increasing with an average of 12 pharmacies adopting the practice 
each year from 1988 to 1993, with a range of 9 to 16 per year. The most recent 
time a pharmacist began supplying needles and syringes to injecting drug users 
was April1994. The 1994 figures are to July of that year when the survey was 
conducted. 
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Factors influencing the change. 
When asked to rate the degree of importance of a number of factors in 
detennitting th.eir decision tfl start selling needles and syringes, the vast majority 
of current sellers (92%) rated as important or very important that they became 
more convinced that the supply of injecting equipment was essential to the 
reduction of transmission of disease (see Figure I). The belief that disruption was 
unlikely to occur in their pharmacy was important or very important to almost 
half ( 48%) of selling pharmacists. In regards to the law, 40% of current sellers' 
decision to supply was influenced by the fact that no prosecutions had been laid 
for selling needles and syringes to injecting drug users and 25% rated the 
impending legislative change as important or very important. Only 9% saw it as 
an important commercial decision. A number of other reasons were given, the 
most frequent (!! - 5) being response to the Health Department of Western 
Australia's initiatives and/or the Pharmaceutical Council's recommendations. Other 
reasons reported by a small number of individual pharmacists included: refusal to 
supply attracted abuse, L'ueats and general intimidation; the possible reduction of 
burglaries; the hope that used syringes would be properly disposed of; as a 
community service; and because customers asked for them. For one phannacist 
the decision was influenced by more personal considerations for he/she stated that 
"if the person carrying HIV transmitted it to my child and it could have been 
prevented I r.ould not 'forgive myself so this was a semi-personal decision". 
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Other factors 
Viable commercial 
practice 
Possible legislation 
change 
No prosecutions laid 
Belief that disruption 
unlikely 
CJ Very important 
• Important 
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%Current Sellt:rs 
Figure 1. Factors influencing current sellers' decision to sell needles and syringes 
to injecting drug users_ 
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Future intentions. 
Of the 101 current sellers 93% (!l ~ 94) intend to continue selling needles and 
syringes to injecting drug users, 2% (!l ~ 2) indicated they did not intend to 
continue selling, 2% were ambivalent about continuing the practice ~ .. 11d 3% 
(!l ~ 3) failed to indicate their future intentions. One metropolitan pharmacists 
explanation for discontinuing sales was that he was waiting until the new 
legislation was sorted out as the Pharmacy Guild was still figuring out what could 
be sold by pharmacists without paperwork hassles. The other current seller's 
reason for ceasing sales, a country pharmacist, was because of the requirement for 
data collection and the time required, together with no training being provided. 
For one pharmacist ambivalent about his future selling practice, the indiscriminate 
disposal of needles and syringes and the drug users' apparent lack of respect for 
themselves and the community caused conc-::m. However, at various times he felt 
that, as a community pharmacist, he was the best equipped person to handle the 
distribution of needles and syringes. The other ambivalent pharmacist felt there 
was possibly enough outlets for users to purchase syringes. 
Past selleB 
As reported earlier 9 (64%) of the 14 nonsellers had previously sold needles and 
syringes to injecting drug users but had discontinued the practice. Of these past 
sellem three stopped supplying needles and syringes to injecting drug users in 
1990, 3 stopped in 1993 and 2 stopped selling in 1994. One pharmacist failed to 
indicate when he/she stopped selling. 
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Factors influencine the discontinuatioD of supply. 
Important factors in phannacists' (!! ~ 9) decision to stop selling needles and 
syringes to injecting drug users are shown in Figure 2. The factors most often 
reported as important or very important in their decision to stop supply was 
disruption in their pharmacy by 89% (!! ~ 8) of past sellers followed by incidents 
that threatened the safety of staff and/or other customers by 78% (!! ~ 7) and 
ethical concerns about the practice by 55% (!! ~ 5). Less than half reported 
shoplifting, community attitudes to the practice and the legal ramifications as 
factors in their decision to stop selling. Other factors important to the decision of 
past sellers to stop supply included: the incidence of indiscriminate disposal of 
needles and syringes, reported by 2 phanmar,ists; concern about possible 
cancellation of shop insurance due to the number of break-ins experienced, as 
well as the disruption to the phannacisfs home life as a result of ca11-outs in one 
case; and the belief by one phannacist that supplying needles and syringes would 
not reduce the spread of HIV because two or three "users" would come into the 
phannacy at a time and buy a single needle/syringe. 
Future intentions. 
Thirteen nonsellers (93%) indicated that they did not intend selling needles and 
syringes to injecting drug users in the future. Nine pharmacists (64%) said that 
nothing would encourage them to seii injecting equipment to injecting drug users. 
However, three (14%) reported that if there was evidence that drug users were 
receiving counselling or rehabilitation to change their drug use they would sell to 
75 
" r )•.'; 
' ' I; 
! 
Other factors 
Legal ramifications 
Community attitude 
Shoplifting 
Ethical concerns 
Threatening incidents 
Disruption in 
phannacy 
0 10 20 30 40 50 
% Past sellers 
0 Very important 
• Important 
60 70 80 90 
Figure 2. Factors influencing past sellers' decision to stop selling needles and 
syringes to injecting drug users. 
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them, one phannacist would sell if he "thought there was a way of cutting down 
on the problem" and one pharmacist said he would sell if drug users appeared. It 
is interesting that disruption and threats were a major reason for discontinuing 
sales but guarantees of safety did not feature here. 
Facto m 1hat Differentiate Between Current Sellem and Nousellem of Needles and 
Syringes ID Injecting Drug Users 
To detennine the factors that differentiate between sellers and non-sellers of 
needles and syringes to injecting drug users variables likely to impact on practice 
were correlated with current practice (see Table 6). The results reveal a 
relationship between a number of variables and current selling practice indicating 
possible factors that influence phannacists' decision about supplying sterile 
injecting equipment. These factors are as follows: 
I. Current sellers are slightly more likely than nonsellers to regard the 
HIV virus as a serious health risk to injecting drug users,! (113) ~ .19, 11 < .05. 
2. Current sellers are more likely to think the use of non-sterile injecting 
equipment is a hazard to injecting drug users, ! ( 113) = .30, 11 < .0 I. 
3. In relation to the role pharmacists should play concerning HIV and 
hepatitis current sellers are more likely to think pharmacies should sell needles 
and syringes to injecting drug users,! (113) = .67, 11 < .01. 
4. Current sellers are more likely to think that injecting drug users should 
obtain needles and syringes from pharmacies, r (113) ~ .65, 11 < .01. 
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Table6 
Correlation between selling practice and oossible influencine: factors 
Factors 
Seriousness ofHIV to the general public 
Seriousness ofHIV to IDUs 
Seriousness of hepatitis C to the general public 
Seriousness of hepatitis C to IDUs 
Significance of hazard of injecting drug use to the general public 
Significance of hazard of injecting use to IDUs 
Pharmacists should sell needles and syringes 
IDUs should obtain needles and syringes from pharmacies 
ID Us should pay for needles and syringes 
Support of W A Health Departments strategy 
Disruptive incidents in phannacy 
Dispense methadone 
Current legal status of needle anu syringe supply 
Attitude to injecting drug use and ID Us 
Year of registration 
Experience as phannacist 
Time in present phannacy 
Age 
Gender 
Number of staff 
Location of pharmacy 
Mean hours open weekdays 
Mean hours open weekends 
Unemployed customers 
Student customers 
Elderly customers 
Young families as customer group 
Region 
Note. IDUs ~Injecting drug users. 
*p < .05. **p < .Ol. 
r 
.08 
.19* 
.04 
.16 
.05 
.30** 
.67** 
.65** 
.26** 
.05 
-.37** 
.05 
-.12 
.02 
-.07 
.08 
.09 
.ll 
-.09 
.12 
.06 
.07 
.09 
.20* 
.09 
-.06 
.09 
.05 
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5. Current sellers are more likely to think that injecting drug users should 
pay for needles and syringes, r ( 113) ~ .26,Jl < .0 I. 
6. Nonsellers are more likely to report disruptive incidents in their 
pharmacy concerning injecting drug users, r (113) ~ -.37, I!< .01. 
7. Current sellers are more likely to indicate unemployed as a large 
customer group, r (113) ~ .20, ll < .05. 
Other variables tested revealed no significant relationship to supply practice. 
While these results reveal the significant factors differentiating between current 
sellers and nonsellers, a more detailed description of the findings of particular 
interest are presented in the following section. 
Health Risk of RIV and HeJlatitis C 
Overall 99% of phannacists view HIV as a serious or very serious health risk to 
injecting drug users and 81% think it is a serious or very serious risk to the 
general public. In comparison hepatitis C is viewed as serious or very serious to 
injecting drug users by slightly fewer pharmacists with 93%, though more 
strikingly, only 68% view hepatitis C as a serious or very serious health risk for 
the general public. Figures 3 and 4 show the degree of seriousness with which 
current sellers and nonsellers view these blood-borne viruses. As would be 
expecte<> the data indicates that both current sellers and nonsellers believe that 
these viruses are both more serious for injecting drug users than for the generaJ 
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Figure 3. Current sellers view of the seriousness of HIV and hepatitis C to the 
general public and to injecting drug users. 
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Figure 4. Nonsellers' view of the seriousness of HIV and hepatitis C to the 
general public and to injecting drug users. 
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public. The only significant difference between current sellers and nonsellers 
among variables in this group was that current sellers were slightly more likely 
to regard HIV as a serious risk to injecting drug users. as previously shown. 
Health Hazanl of Non-sterile InMng Equipment 
Almost all pharmacists (98%) consider the use of non-sterile injecting equipment 
as a significant or very significant health hazard to injecting drug users and 73% 
consider it a significant or very significant health hazard to the general public. In 
Figures 5 and 6 the degree of significance current sellers and nonsellers place on 
the use of non-sterile injecting equipment to these groups is shown. For injecting 
drug users 99% of current sellers and 85% of nonsellers viewed the use of non-
sterile injecting equipment as a significant or very significant health hazard. This 
finding was significant and indicated that current sellers were somewhat more 
likely to think injecting drug users were at risk with the use of non-sterile 
injecting equipment. 
Training 
Only six pharmacists (5%), all of whom were current sellers, reported receiving 
any training regarding the sale of needles and syringes to injecting drug users. Of 
these, two indicated they received training tluough the Pharmaceutical Council, 
two by the Western Australian Alcohcl and Drug Authority and one by the 
Health Department of Western Australia. One pharmacist had twice received 
training, frrstly at Boots Pharmacies in London in 1976 and more recently in 
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Figure 5. Current sellers' view of how significant a health hazard the use of non~ 
sterile injecting equipment is to the general public and to injecting drug users. 
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Figure 6. Nonsellers' view of how significant a health bazard the use of non·· 
sterile injecting equipment is to the general pubJic and to injecting drug rJSers. 
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Western Australia, although the body conducting the later training was not 
specified. Five pharmacists had training in 1990 and one in 1992. No statistical 
analysis was conducted concerning training due to the sma11 number of cases. 
Support of lhe Health Depat1ment of Western Australia's Hmm 
Minimisafioo Stra!Egy 
Of the I J:l pharmacists who responded to this question 82% (!! ~ 92), comprising 
89% (!! ~ 90) of current sellers and 14% (n ~ 2) of nonsellers indicated that they 
support the Health Department of Western Australias strategy to sell needles and 
syringes to injecting drug users for harm minimisation reasons. Ten percent 
(!! ~ 10) of current sellers do not support the strategy, yet still supply needles and 
syringes. Conversely, 14% (!! ~ 2) of nonsellers do support the strategy. There is 
some difficulty in interpreting this data. While these figures may accurately 
represent phannacists' stance on this issue it is possible that the use of the word 
'support' in the question may have resulted in some ambiguity among phannacists. 
It could be that some pharmacists interpreted support as meaning selling. They 
may also not agree with the strategy ao a whole, but support the supply of 
injecting equipment by pharmacists. For this reason, if the study were to be 
repeated, the question could be reworded to ensure a clear understanding. 
Disruptive Incidents 
A total of 37 pharmacists (32%) overall have experienced disruptive incidents 
concerning injecting drug users in their pharmacies. This included the majority of 
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nonsellers (71%,!! ~ 10) with a further two not responding to this question, and 
27"/o (!! ~ 27) of current sellers. As previously noted this was a significant 
difference between current sellers and nonsellers. 
The types of incidents experieneed by pharmacists were coded into four 
categories with the results presented in Table 7. Of the 37 pharmacists who 
experienced disruptive incidents 81% specified the nature of these incidents. 
Some pharmacists have experieneed multiple disruptive incidents but each type of 
incident is accounted for only once for each respondent. Where a phannacist 
experienced more than one type of incident they were counted in each appropriate 
category. 
Table 7 
Disruptive incidents experien~ed by pharmacists 
Current Sellers Nonsellers 
(!! ~ 101) (~ ~ 14) 
Type of Incident n(o/o) n(%) 
Aggression/Abuse 17(17) 6(43) 
Theft 2(2) 4(29) 
Demands for attention 1(1) 2(14) 
Disoriented/intoxicated customers 5(5) 1(7) 
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The most common problem experienced was aggression and/or abuse to the 
pharmacist and/or staff which was experienced by 43% of nonsellers and 17% of 
current sellers. Aggression and abuse ranged from complaints to rudeness, 
swearing, arguments, threats and violent behaviour, and was usually in regard to 
either the cost of Fitpacks, temporary unavailability of Fitpacks, refusal to sell 
single needles and syringes, refusal to sell other drugs, or the pharmacy's policy 
not to supply injecting equipment to injecting drug users. In four cases the abuse 
was associated with the dmg affected condition of the customer and their 
impatience and demands for immediate attention. 
The second most common incident was theft which was experienced by 4 
nonsellers (29%) and 2 sellers (2%). Four of these cases were shoplifting, one 
nonselling pharmacist had experienced various hold-ups and robberies and another 
had his pharmacy broken into three times and each time the only things stolen 
were syringes and Fitpacks. Other incidents arose from demands for immediate 
attention in 3 cases. and disoriented or intoxicated customers in 6 cases. Two 
phannacists expressed concern about the effects of disoriented or intoxicated drug 
users on other .customers. 
' 
Further statistical analysis to determine whether aggression/abuse was the major 
difference between current sellers and nonsellers was not conducted as expected 
frequency of at least 5 in each cell is required to do a chi-square test so cell sizes 
were too small. 
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Handline:; of disruptive incidents. 
Of ti1e 37 pharmacists who experienced disruptive incidents 83% (l! ~ 31) 
indicated how they handled the incidents, the results of which were coded into 
four categories and are summarised in TabJe 8. Verbal conciliation was the most 
often used strategy and was adopted by 30% of this group of pharmacists 
including 36% of current sellers and 15% ofnonsellers. A further 19% asked or 
told the customer to leave or go elsewhere. Of the pharmacists in the "other" 
category 2 current sellers and I nonseller ignored the incidents, 2 current sellers 
called the police, I current seller claimed they did not handle t.he incident well, 
Table f 
StratciPes used by pharmacists experiencing disruptive 
incidents 
Current Sellers Nonsellers Total 
(n ~ 25) (!) ~ 13) (n ~ 37) 
Strategy n(%) !1(%) '!(%) 
Verbal conciliation 9(36) 2(15) 11(30) 
Asked person to leave 6(24) 1(8) 7(19) 
Served quickly 2(8) 3(23) 5(13) 
Other 6(24) 2(16) 8(22) 
Total 23(85) 8(80) 31(84) 
Note. Six pharmacists did not indicate how they handled 
disruptive incidents. 
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one current seller physically fought the drug users off and one said he/she 
handled incidents with a great deal of problem and claimed there is no support for 
pharmacists. 
Olher Problems 
Current sellers were also asked whether they had experienced any or any other 
problems in their phannacy as a result of selling needles and syringes to iqjecting 
drug users. Sixteen percent(!!= 16) reported other problems. Of these, 8 
reported theft which included shoplifting in six cases, one break-in and a number 
of burglaries experienced by one phannacist Requests for single needles resulted 
in problems for four phannacists who had a 'Fitpack only' policy with two of the 
pharmacists reporting abuse. Other problems experienced by individual 
phannacists included: unhappy parents who discovered children using syringes 
they had purchased at the pharmacisrs store; 'undesirables' tending to be off-
putting to other customers and lowering the image of the phannacy; regular 
customers being 'appalled' to see needles and syringes being sold to injecting drug 
users~ injecting drug users trying to gain credit or unauthorised prescriptions; and 
one country pharmacist reported police enquiries (anonymous, no names 
requested) of usage, sales times and amounts. 
Many of the problems experienced by phannacists were of the same type as those 
reported as disruptive incidents previously, indicating a difference in the way 
phannacists categorised the incident or problem. This means that the comparison 
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between current sellers and nonsellers regarding disruptive incidents is possibly 
not correct due to the different perception of the incident If the study were to be 
repeated some modification of the questionnaire would be needed in this area to 
avoid this confusion. 
Current J..ew!l Sllllus of Needle and Syringe Supply to Injecting Drne UseJS 
When asked the current legal status regarding the sale of needles and syringes to 
injecting drug users 60% (!! = 69) of pharmacists indicated that the practice was 
legal, 17% (!! = 20) of whom qualified this by adding that approval was required 
(see Table 9). Six percent l!! = 7) of pharmacists, all current sellers, reported that 
the practice was illegal. One third of pharmacists either did not know or were 
unsure of the current legal status, gave invalid answers or failed to respond to the 
question. One possible explantion for this mixed response could be that the new 
legal status was causmg some uncertainty for pharmacists. 
To conduct the correlation analysis between sellers and nonsellers this variable 
was re-coded into three groups including legal (consisting of the. legal and legal 
with approval categories), illegal and missing (consisting of the don't 
know/unsure, invalid and missing categories). As reported previously there was 
no significant difference between current sellers and nonsellers on these results. 
Influence of the current legal sfntus. 
When asked how the current legal status infloenced their practice regarding the 
·~~,~-------
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Table 9 
Pharmacists' view of the current legal status of needle and 
syringe supply to ID Us 
Current Sellers Nonsellers Total 
Legal status n(%) n(%) n(%) 
Legal 45(45) 4(29) 49(43) 
Legal with approval 16(16) 4(29) 20(17) 
Illegal 7(7) 0(0) 7(0) 
Don't know/unsure 12(12) 2(14) 14(12) 
Invalid 4(4) 0(0) 4(3) 
Missing 17(17) 4(29) 21(18) 
Total 101(100) 14(101). 115(99). 
Note. IDUs = injecting drug users. 
'Percentages do not add to I 00 due to rounding. 
sale of needles and syringes to injecting drug users of the 63% (n = 72) of 
pharmacists who gave valid answers 84% (!1 ·'53) of current sellers and 100% 
(!! = 9) of nonsellers indicated it did not influence their practice. Other answers 
received were dependent on the response to the previous question. 
AUirudes ro injecting drug use and injeding drug users 
As outlined in Chapter 3 the positive statements on the scale measuring 
pharmacists' attitudes to injecting drug use and injecting drug users were re-coded 
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and the internal consistency of the scale was tested with a coefficient alpha of .68 
indicating that the scale is moderately reliable. 
Pharmacists average scores on the I 0 questions of the scale ranged from 1.3 to 
4.2 with a mean of 2.74 (SD =.51). These figures reveal that on average 
pharmacists are slightly negative in their attitude to injecting drug use and 
injecting drug users. As already shown, there was no difference between current 
sellers and nonsellers for this variable indicating that supply practice was not 
influenced by pharmacists attitudes to injecting drug use and injecting drug users 
as measured by this scale. 
Nonselle111' Cunent Reasons for not Selling 
Figure 7 depicts tl1e degree of importance nonsellers place on a number of factors 
in determining their current decision for not selling needles and syringes to 
injecting drug users. The factor rated by almost all nonsellers (93%) as 
important or very important was concern about possible aggression towards staff 
of the pharmacy. Almost three quarters (71%) did not want the type of people 
who use drugs coming in1:o their pharmacy. For 21% the current legislation and 
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Figure 7. Factors influencing nonsellers' current decision not to sell needles and 
syringes to injecting drug users. 
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possible prosecution was of concern indicating that these phannacists were 
probably unaware of the change in legislation. 
Other Issues 
Almost a third of pharmacists (31%) added comments expressing a wide range of 
opinions concerning the issue of the provision of need.Jes and syringes to injecting 
dmg users. The only issue mentioned by more than 3% of phannacists regarded 
counselling or trea1ment for injecting dmg users which 9% (!! = I 0) of 
pharmacists alluded to. 
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CHAPfER FIVE 
Discussion 
The Extent of Current Needle and Syringe Supply 
The findings of this study indicate that the vast majority of phannacists in 
Western Australia have adopted the practice of selling needles and syringes to 
injecting drug users. The finding that 88% of Western Australian pharmacists are 
currently supplying sterile injecting equipment exceeds the former approximation 
of 78% (Keny,I994) of pharmacists who sell Fitracks. As only 3% of suppliers 
do not supply Fitpacks, this is not enough to account for the difference. This 
difference may be due to sampling bias or, as Kerry's figures were obtained from 
order forms for Fitpacks it could be that some pharmacists sold very few Fitpacks, 
did not often re-order and were thus incorrectly counted as nonsuppliers. This was 
the experience of Greig (1992) who found that many pharmacists contacted who 
were thought to be nonparticipants in !he Fitpack program because they were not 
on the re-order lists, had every intention of participating but were not yet ready to 
re-order. The proportion of sellers in the current study is closer to the 86% 
achieved in the telephone survey conducted by Greig in 1992. Greig's sampling 
procedure, however, differed in that a non-randomised selection process was 
adopted in an unsuccessful attempt to obtain a discrete nwnber of current sellers, 
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nonsellers and past sellers. 
An unexpected result in the current study is that a higher proportion of country 
pharmacists (90%) supply needles and syringes to injecting drug users than do 
metropolitan pharmacists (86% ), although this difference was not statistically 
significant. However, the proportion of country pharmacists currently supplying 
represents a vast increase since 1990 when Swensen, Westlund and Baker (1990) 
found that according to re-order forms, 25% were providing needles and syringes 
through the SS5 Pack prognun. At that time 56% of metropolitan pharmacists, 
more than double the proportion of those from the country, were involved in the 
supply of SS5 Packs. These figures may indicate that pharmacists throughout the 
state have responded to the call to help prevent serious blood-borne diseases and 
are playing an important role in the government's harm minimisation strategy 
although the points noted above should caution this interpretation. 
Although increasing numbers of pharmacists have adopted the practice of selling 
needles and syringes to injecting drug users 8% were past sellers who had 
reversed their decision to sell. This is a higher proportion than the 3% of past 
sellers (when taking into account that two respondents still sold single needles) in 
Greig's (1992) evaluation of the Fitpack program. However, the figure compares 
more favourably with Mullin's (1990) Victorian study where 14% of respondents 
were past sellers and 59"/o current sellers, although only a 37.8% response rate 
was achieved by Mullins so there was less cha.~ce of the findings being 
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representative of the total population. In earlier Victorian studies 5% (Jennings, 
1987) and 8.5% (Monash Medical School, 1987) of participants were past sellers 
and these too had a smaller proportion of current sellers (63% and 45% 
respectively) in comparison to Western Australia with 88%. These figures indicate 
that less pharmacists cease supply in Western Australia 
Facto" Influencing C!Jan&es to Supply Pmctice. 
The most compelling factor that encourag~.d pharmacists to seU needles and 
syringes to injecting drug users was their belief that the supply of sterile injecting 
equipment was essential for the reduction of the transmission of disease. It is clear 
that the implications of the use of non-sterile injecting equipment by persons 
injecting illicit drugs is regarded seriously by pharmacists. While only five 
participants specifically mentioned that their decision to seil was influenced by the 
Health Department of Western Australia's and/or the Pharmaceutical Council's 
recommendations, it is clear that the encouragement from these bodies and 
education about the seriousness of the problem has influenced the participation in 
needle and syringe sales in Western Australia. 
These findings were similar to the experience of other states. For example, Tsai, 
Gob Webeck and Mullins (!987) reported a significant favourable shift in 
phannacists' attitudes towards selling in New South Wales after the public launch 
of the Anti-AIDs Kit in 1986. ln Victoria the Monash Medical School (1987) 
reported that many of the current sellers commented that they had adopted the 
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practice in respci1se to the policy guidelines of the Pharmaceutical Society. 
Moreover, the implications from other studies were that because the majority of 
pharmacists acknowledged HIV as a serious risk to injecting drug users the sale 
of injecting equipment was taken up (Jennings, 1977; Cuatt, 1989). 
The other important factor that influenced many cu.rent sellers (48"/o) in this 
study was that disruption was unlikely to occur. However the results show that 
one third of pharmacists in the study have experienced such incidents and for past 
sellers, disruption in the pharmacy and threatening incidents were the two 
commonest factors influencing the discontinuation of supply. This was similar to 
the fmdings in Greig's (1992) earlier studies which found that the major cause for 
pharmacists ceasing to participate in Fitpack sales were fear of further assault, 
break-ins and theft. Pharmacists used a range of strategies to handle disruptive 
incidents, the commonest being verbal conciliation. However, a number had 
difficulties and either ignored the incidents or used stronger measures. Only a 
small minority of pharmacists have received any training in regard to selling 
needles and syringes and it may be that this needs to be rectified. 
Future Intentions 
It is clear that the vast majority of pharmacists intend to continue to supply 
needles and syringes to injecting drug users. However, there are some who 
indicated that they may change their mind about selling practice. For example, 
two sellers in the current study indicated that they intended to discontinue sales 
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and another two were ambivalent about their selling practice. On the other hand 
one of the nonsellers intended to sell on request and, although the other nonsellers 
said they did not intend selling in the future, four qualified this by stating the 
grounds that would encourage them to do so. There may therefore be some slight 
fluctuation in selling practice but it seems unlikely that all pharmacists will 
participate. 
Fa<tors That DIITerentiate Current Sellers from Nonsellers 
There was Jittle swprise in some of the results regarding the significant factors 
that differentiated current sellers from nonselJers. That current sellers are more 
likely to think that pharmacists should sell needles and syringes to help prevent 
HIV and hepatitis C and injecting drug users should obtain needles and syringes 
from pharmacies, and pay for them, is •elf explanatory. It terms of demographics 
there were no differences between sel1ers and nonsellers except for the finding 
that unemployed people were slightly more likely to be customers in current 
sellers' pharmacies, though the relationship between these factors is unclear. 
In addition, current sellers were more likely than nonsellers to believe both that 
HIV was a serious health risk to injecting drug users and that the hazard posed by 
the use of non-sterile injecting equipment was serious to injecting drug users. 
However interpretation of these fmdings is a little difficult as the majority of 
nonseiJers were past sellers. 
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Disruptive Incidents in the Pharmacy 
Possibly the most important factor differentiated between sellers and nonsellers 
was that nonsellers (71%) were more likely than current sellers (27%) to have 
experienced disruptive incidents in their pharmacy. This is reflected in the finding 
that disruption in the pharmacy and incidents that threatened staff or other 
customers were factors in the cessation of needle and syringe supply for the 
majority of past sellers. OveraU, aggression and/or abuse were the most common 
incident experienced by pharmacists and for nonsellers the possibility of 
aggression is the commonest factor influencing their current reason for not selling. 
It appears that support and/or training (previously alluded to) for pharmacists to 
help deal with these incidents may be an option to consider. 
HIV and Hepatitis C 
Although the majority of pharmacists overall view HI V and hepatitis C as a 
serious health risk to both the general public and injooting drug users, hepatitis C 
is considered to be less of a risk than HIV for both groups, and while 93% of 
both current and nonsellers think hepatitis C is a serious risk for injecting drug 
users, more current se!Iers view it as very serious. These fmdings somewhat belie 
the current infonnation on the prevalence of these diseases and their transmission. 
Hepatitis C is at least five times more prevalent in Australia than HIV with at 
least 15 times more new infections of hepatitis C each year (W odak & Crofts, 
1993). Moreover the incidence of hepatitis C among inje<1ing drug users is 
extremely high with 80% to 90% of clients in the Perth methadone clinic infected 
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with the virus (Kerry, 1994). Therefore transmission through the sharing of non-
sterile injecting equipment is highly probable. 
One possible explanation for Western Australian phannacists viewing hepatitis 
C as a less serious health risk than HIV is that it is a more recently recognised 
disease than HIV and has not been focused on to the same degree. Less education 
regarding the disease has been forthcoming and this may need to be addressed. 
On the other hand the result may be due to interpretation. It could be that 
pharmacists considered the seriousness of the diseases compared to each other. If 
that is the case then HIV, which almost certainly leads to AIDs and eventual 
death, could be seen as more serious than hepatitis C, which although often 
chronic and sometimes leads to death, has a far better prognosis. Were the survey 
to be repeatc:d some thought would need to be given to rewording these questions. 
Effects of the Legal Status 
Although the sale of needles and syringes to injecting drug users was technically 
illegal in Western Australia until May J994,just prior to the time data was 
collected for this study, it had no significant effect on supply practice although 
25% of sellers reported the impending legislative change was a factor in their 
decision to start selling. Only 3 nonsel!ers (21%) considered it a factor in their 
decision not to sell needles and syringes. In contrast, in Cuatt's (1989) Tasmanian 
study 18 nonsellers (38%) cited their concern about the legalities of supplying 
injecting equipment to injecting drug users as a reason they chose not to make 
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needles and syringes generally available and 45% reported that a change in the 
legislation would encourage them to supply. 
Deterrence Theory. 
It seems that the previous legal sanctions on the sale of injecting equipment to 
drug users has not had a major impact in deterring sales in Western Australia. For 
legal sanctions to be effective punishment must be certain, swift and/or severe 
(Williams & Hawkins, 1986). The fact that needle and syringe supply was 
condoned in Western Australia and that no prosecutions for sales had occurred 
supports the theory of deteiTence. Indeed, for 40% of sellers the knowledge that 
no prosecutions had been laid was an important factor in their decision to sell 
Punishment was not certain, swift or severe as in the classic example of 
deterrence w namely RBT to reduce the incidence of driving under the influence of 
alcohol (Home!, 1988). Punishment was in fact non-existent and with the 
encouragement from the Health Department of Western Australia, the 
Pharmaceutical Council and the Pharmacy Guild to sell needles and syringes and 
the condonement of the practice the number of participating pharmacists has 
continued to increase. Therefore, although a small minority of pharmacists 
expressed some concerns about the legality of the practice it was not a deterrent 
overall. Tasmanian pharmacists on the other hand, were in a dubious legal 
position at the time of Cuatt's (1989) study as the practice was illegal and was not 
condoned by the State Government, and there was less certainty thllt they would 
not be punished, which may be a factor in their finding of only 21% supplying. 
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Attitudes 1o Injecting Dnig Use and Injecting Drug UseJS 
On average phannacists had slightly negative attitudes towards injecting drug use 
and injecting drug users. As there was no significant difference between current 
sellers and nonsellers it is apparent that many current sellers have put aside their 
feelings towards injecting drug users and have adopted the goveromenfs IJllffil 
reduction strategy in the interests of public health. While MacCarthey (1994) 
claimed widespread discrimination of injecting drug users in Australia and that 
they generally experience a poor response from a wide range of service providers 
it appears this is not the case in tltis instance, at least as far as the supply of 
needles and syringes goes. 
The findings are similar to those of Abed and Neira-Munoz (1990) who found 
that the majority of general practitioners were prepared to help drug dependents 
despite having negative attitudes towards them on a number of counts. There are 
differences between these situations, however, in that phannacists have been 
asked to engage in an illegal activity to help prevent the transmission of serious 
blood-borne disease, not only to the drug user but also from them to the general 
community, and the general practitioners in Abed and Neira-Munoz' study are 
asked about their willingness to treat drug dependence, a far less controversial 
activity. 
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CHAPfERSIX 
Condusions 
The vast majority of both metropolitan an-i country pharmacists in Western 
Australia currently supply needles and syringes to injecting drug users thereby 
ensuring availability in most areas of the state. Pharmacists generally have 
adopted the practice because they believe it is essential to the reduction of the 
transmission of disease. which is consistent with the trend found in other studies. 
Although 8% of pharmacists were past sellers this proportion compares favourably 
with the findings in other states indicating that less pharmacists in Western 
Australia have ceased supply. However it appears that the proportion of 
participating pharmacists will fluctuate slightly and it is unlikely that th "re will be 
total participation. 
While the belief that disruption was unlikely to occur in their pharmacy 
influenced almost half of current sellers in their decision to supply, this was not 
borne out by the experience of one third of the total pharmacists and indeed, 
along with tlrreatening incidents, was the major cause for past sellers to cease 
supply. Disruptive incidents were also the most important factor that differentiated 
between current sellers and nonsellers with nonsellers experiencing significantly 
W3 
more. The incidence of such incidents and the effect that they have on supply 
practice may indicate the need for support or training for pharmacists, especially 
in view of the fact that aggression and/or abuse is the major type of incident and 
many pharmacists seem to not have appropriate strategies for handling the 
disruption. Further research may need to be earried out to determine whether 
phannacists require support and/or training for conducting their business in 
relation to the supply of injecting equipment. 
HIV and hepatitis C were both viewed by pharmacists as serious diseases 
although hepatitis C to a lesser extent. There was some difficulty inteJpreting this 
data but there may be some implications for more education generally concerning 
the greater possibility of the transmission of hepatitis C. 
While phannacists on average had slightly negative attitudes to injecting drug use 
and injecting drug users, this had not significantly affected supply practice which 
may reflect pharmacists' commitment to public health. Pharmacists also were not 
unduly influenced by the former legal sanctions on the sale of needles and 
syringes and these findings could be viewed as supporting the the01y of 
deterrence. 
It is not known how representative this sample is of the wider population of 
pharmacists, however the random sampling technique and the high response rate 
would have enhanced it and the findings in many ways reflect the trends in 
~imilar studies 
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APPENDIX A 
POISONS ACT 1964 
Form 14 
APPLICATION FOR APPROVAL OF NEEDLE AND SYRINGE PROGRAM 
I ........................................................................................... of.. ............... . 
.................................................. hereby apply on behalf of .................... . 
for the approval of the following needle and syringe program .................... : ........................................ . 
······························································································································································ (specify preclse(IJ I he octil•iries, and the person:r or doss of persons conducting /host aCiivilie.~. that conslitutt the 
program). 
1. The program v.rill be conducted at ............................................................................................... . 
........................................................ ................................................... ............................................... .. 
(specify place or places) 
2 . The program v.rill be conducted at or between the following times ....... 
................................................................... ........................... ................. ············· .......................... . 
(specijj·fimes) 
3. The Co-ordinator of the program will be ............................................... .. 
(specify namt and address ojCa-ordinatar) 
Signature of Co-ordinator Signature of Applicant 
Date: 
Note: I) Return to: 
2) For more infonnation 
contact: 
Medical Co-ordinator 
Communicable Disease Control Unit 
PO Bo>: 8172 
Stirling Street 
PERTH WA 6000 
Ms Kathryn Kerry 
(09) 227 3777 
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APPENDIX~ 
The PHAR:'<!ACY GUILD of AUSTRALIA 
NATIONAL SERVICES 
Facsimile Transmission 
DATE: JULY71994 
TO: J. NEWBEY 
HEALTH & HUMAN SERVICES DEFT. EDITH COWAN UNIVERSITY 
FAX: (09) 227 7302 
f:'ROM: Murray Aees- Direclor of National Services Division 
PHONE: (03) 810 9930 
FAX: (03) 818 2590 
AE: Survey No. 151 
Number of pages including cover sheet: 2 
___________ ,,,,,.,.,._,,. ______ _ 
Message 
Dear June. 
Please find our survey certificate following. 
PI east::: use it to convey to our members, our approval of your study. Should you consider that any key 
findin~s may be of into:rest to our 5000+ members then we would be glad to distribute/publish them 
when~ possible. · 
Thank you for involving Th!. Pharmac)· Guild of Australia. 
Good l~ck \\1~r research. 
Regard~# 
c.c. :\1r H. \V. G. Cuthill- Chainnan 
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§lJ[JR. VJEY cCJEJR-1fJ[]!?J[(CA 1rlB 
THE PHARMACY GUILD OF AUSTRALIA 
No ... 151.. 
This is to certify that the documentation for the following 
survey has been presented for examination and that the Guild 
has no objection to member participation 
CONDUCTED BY: J. NEW BEY- HEALTH & HUMAN SERVICES DHPT. EDnH CO \VAN UNIVERSID' 
FOR (CLIENT): AS ABOVE 
PERIOD OF FIELD WORK: JULY TO AUGUST 
METHOD OF SURVEY: MAIL 
STATES/AREAS TO BE COVERED: WESTERN A USTRAL!A 
RATING: I Bl I 
Signature of Approving Officer: ......................................................................... Date: JULY 61994 
PLEASE NOTE: The Pharmacy Guild of Auslralia has examined lhe proposed qucsli ns to be i.lskcd in this survey and has gh•cn approval fur 
.members to be tpproache.d about the survey. Such approval does not obligme any phmmt~cisi/Guild member to p:trlicipalc in the ~un•cy. The 
:tHmice of whether or no{ ro participate is left to I he individual. 
APPENDIX C 
Initial Telephone CaD 
Hello, may I speak to .......... please? 
This is June Newbey from &lith Cowan University. We are currently 
conducting a state-wide study of pharmacists' attitudes and practices in relation to 
the supply of needles and syringes to injecting drug users. You are one of only 
130 pharmacists selected to take part. 
This phone call is to inform you of the study which entails completion of a 
questionnaire which I will forward to you. The study and the questionnaire have 
been discussed with both the Pharmaceutical Council of W A and the Pharmacy 
Guild. 
To ensure the results of the survey are genuinely representative of Western 
Australian pharmacists your participation is iroportant and valuable. You may be 
assured that the information you supply will be confidential. May I forward a 
questionnaire to you. 
H Yes: Thank you for your cooperation. I will post the questionnaire and a 
stamped addressed envelope to you within the next day or two. I would appreciate 
it if you could complete the questionnaire and return it within the next two weeks. 
Finally, could you please tell me whether you currently supply needles and 
syringes to injecting drug users? Thank you. Goodbye. 
H No: Could you please tell me the reason you do not wish to participate? 
One fmal thing, do you currently supply needles and syringes to injecting drug 
users? Thank you for your time. Goodbye. 
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APPENDIKD 
THE SUPPLY OF NEEDLES AND SYRINGES 
TO INJECTING DRUG USERS: 
ATTITUDES AND PRACTICES OF PHARMACISTS 
IN WESTERN AUSTRALIA 
SURVEY OF WESTERN AUSTRALIAN 
PHARMACISTS 
EDITH COW AN UNIVERSITY 
2 Bradford Street 
Mount Lawley W A 6050 
SURVEY OF WESTERN AUSTRALIAN PHARMACISTS 
Thank you for your assistance in this endeavor. The following 
questionnaire contains 43 brief questi0ns related to the 
provision of needles and syringes. 
"Your pharmacy" refers to the pharmacy in which you are 
currently located. "Injecting drug users" are individuals 
known or believed to be injecting drugs illicitly. 
Please answer ALL questions. 
(Unless specified please circle only one number represent.l.ng 
the answer you most agree with). 
PUBLIC HEALTH 
The first set of questions concern public health issues in 
Western Australia. We'.d like to know your thoughts on. these 
matters. (Please circle one number on each scale). 
1. How serious a health risk to the general public do 
you believe the HIV virus is in Western Australia? 
'~~~~~-~----~·'------~·~~----5 Not at all Not very Unsure Serious Very 
seriouo serious serious 
2. How serious a health risk do you believe the HIV virus 
is for injecting drug users in western Australia? 
';:--7;;--;:;;:;:-2--------o~'::::::-----o:::-:'=::--ucs Not at all Not very Unsure Serious Very 
serious serious serious 
3. How serious a health risk to the general public do you 
believe Hepatitis C is in Wester!l Australia? 
Not ~t c,-,.,,,--,N-oc-t 2vce-ry=---ouo-n;'ucrc-e---,s=-ec:ious'----v~;ry 
serious serious serious 
4. How eerie·"• a health risk do you believe Hepatitis C 
is to injecting drug users in Western Australia? 
Not ~:;t-a"l"l;--;;N;-:o-;:-t 2v::e=-ry~--"u""n;·~ur:::e:-----,S::-e:::i"o=u"s:---,-v~'ry 
serious serious serious 
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5. Do you think that the use of .non sterile injecting 
equipment by injecting drug users represents a 
significant health hazard to the general public? 
1 2 '=--::=,4 5 Not at all Not very Unsure Significant Very 
significant significant significant 
6. Do you think the use of non-sterile injecting 
equipment by injecting drug users represents a 
significant health hazard to injecting drug users? 
l:;-:=-;;::;-·2=::--='=--;;,=4 5 Not at all Not very Unsure Significant Very 
significant significant significant 
7. What role do you think pharmacists should play in 
relation to the prevention of HIV and Hepatitis? (More 
than one number may be circled). 
1 Provide advice, information and counselling. 
2 Provide information and pamphlets on HIV, Hepatitis 
and injecting drug use. 
3 Sell needles and syringes to injecting drug users. 
4 Sell condoms. 
5 Provide free sterile needles and syringes on receipt 
of used equipment. 
6 Pharmacists should play no role. 
7 Other (Please specify) __ ~---------------------------
NEEDLE AND SYRINGE DISTRIBUTION 
The next set of questions. concern the distribution of needles 
and syringes to injecting drug users. 
8. Where do you think injecting drug users should obtain 
needles and syringes from? (More than one number may 
be circled) . 
1 Hospitals 
2 Drug treatment agencies 
3 Pharmacies 
4 Police Stations 
5 Doctors' surgeries 
6 Community Health Centres 
7 Outreach vans 
8 Needle Exchanges 
9 Vending Machines 
10 None of the above 
11 Needles and syringes should not be supplied to 
injecting drug users. 
12 Other (Please specify) 
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9. How do you think needles 
to injecting drug users? 
circled). 
- - ---·--·-·----~~'--'-'-··'~·-· ... ..:.. ..... 
and syringes should be SuPplied 
(More than one number may be 
1 Injecting drug users should buy needles and 
syringes. 
2 Injecting drug users should exchange used needles 
and syringes for new equipment. 
3 Needles and syringes should be supplied free to 
injecting drug users. 
4 Needles and syringes should not be supplied at all 
to injecting drug users. 
10. Does your pharmacy have a policy regarding the sale of 
needles and syringes to injecting drug users? 
1 Yes 
2 No 
If Yes: 
lOa. What are the main pointa o£ your policy regarding 
the sale of needles and syringes to injecting drug 
users? 
11. Have you had any training regarding the sale of needles 
and syringes to injecting drug users? 
1 Yes 
2 No 
If Yes: 
lla. In what year did you have training regarding the 
sale of needles and syringes to injecting drug 
users? 
Year ____ _ 
llb. Which organisation conducted the training regarding 
the sale of needles and syringes to injecting drug 
users? 
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12. Do you support the Health Department of Western 
Australia 1 S strategy to encourage pharmacists to sell 
needles and syringes to injecting drug users for harm 
minimisation reasons? 
Yes 
2 No 
CURRENT PRACTICES 
Now we would like to know about your practices in relation to 
the supply of needles and syringes. The following questions 
relate to the pharmacy in which you are currently located. 
13. When did you begin to supply needles and syringes to 
injecting drug users? 
Month ·Year 
14. How important were the following in determining your 
decision to start selling needles and syringes to 
injecting drug users? (Please circle one number on 
each scale). 
14a. I became more convinced the that supply of needles 
and syringes was essential for the reduction of 
transmission of disease. 
1 2 3 ,.--c,---~=.,.· 5 
Not at all Not very Neutral Important Very 
important important important 
14b. It became clear that the legislation was going to 
change. 
1 2 3 4 5 
Not at all Not very Neutral Important Very 
important important important 
14c. It became clear that disruption to my pharmacy was 
unlikely to occur. 
Not ~:-t --,a-,1"'"1-"""N'""o""t 2 v ery•=--""'N"e""u· ~"ra"1;---,Im=p=-oc:·:-t a"n7t--"v"'e0 
important important important 
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14d. It became obvious that no-one was being prosecuted 
for selling needles and syringes. 
Not ~;:-t -=a"r'r--;:;N;::o;:-/::ve:::ry:::---;;N;::e::-u. ~·=r:-a ,,--c;rm=p=o:-·:tan t Ve ~ 
important important important 
14e. I saw the provision of needles and syringes as a 
viable commercial practice. 
1 2 '~-~~:::· 5 Not at all Not very Neutral Important Very 
important important important 
14f. Other reasons (Please specify) 
15. How do you usually sell needles and syringes? 
1 In Fitpacks 
2 Other (Please specify) 
16. Approximately how many Fitpacks/needles do you sell in 
a typical week? 
Fitpacks 
Needles 
Other 
17. How much do you charge for Fitpacks/needles? 
Fitpacks $ ____ _ 
Needles $ ____ _ 
Other $ ___ _ 
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18. Have you experienced a disruptive incident in your 
pharmacy concerning injecting drug users? 
1 No (Go to Q 19) 
2 Yes (Please specify) ________________________ __ 
lSa. How did you handle the disruptive incident? 
18b. Has the disruptive incident influenced your practice 
of selling needles and syringes to injecting drug 
users in any way? 
1 Yes 
2 No 
If Yes: 
18c. In what way has this influenced your practice of 
selling needles and syringes to injecting drug users? 
19. Have you experienced any/any other problems in your 
pharmacy as a result of selling needles and syringes to 
injecting drug users? 
1 No (GotoQ20) 
2 Yes (Please specify) ____________________ _ 
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If Yes: 
19a. Has this influenced your practice of selling needles 
and syringes to injecting dJ:-ug users in any way? 
1 Yes 
2 No 
If Yes to 19a: 
19b. In what way has this influenced your practice of 
selling needles and syringes to injecting drug users? 
20. Do you intend to continue to supply needles and syringes 
to injecting drug users in the future? 
1 Yes 
2 No 
If No: 
20a. What are the reasons for your decision to no longer 
supply needles and syringes to injecting drug users? 
21. Are you currently involved in dispensing methadone? 
1 Yes 
2 No 
If Yes: 
21a. How many clients do you currently supply with 
methadone? 
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LEGISLATION 
This section focuses on issues related to current legislation 
and how it impacts on your practices. 
22. What is the current legal status regarding the sale of 
needles and syringes to injecting drug users? 
23. In what way has this inflUii!nced your practice regarding 
the sale of needles and syringes to injecting drug users? 
ATTITUDES TO INJECTING DRUG USE AND INJECTING DRUG USERS. 
This section concerns your attitudes to injecting drug use and 
injecting drug users. (Please circle one number on each scale). 
24. Injecting drug users are mindless pleasure seekers. 
Str~"'ng='lC:Cy:---,-A:::g:~:-ee=----;u;:n-::s·~·=re=---;oocic:s:::a~-::re::e:---;S;;:t::r~ngly 
Agree Disagree 
25. Injecting drug use is simply a different kind of life-
style that should not be condemned. 
26. 
27. 
St r~=-ng='l;:-y:---;A:::g~:-e e=----;u;:n-::s~' =r:-e ----,D"'i"s"a ~=-re::e:---;S:::t::r~ng ly 
Agree Disagree 
Injecting drug users are not capable of changing. 
1 2 3 4 5 
Strongly Agree Unsure Disagree Strongly 
Agree Disagree 
Injecting drug users are criminals by nature. 
1 2 3 4 5 
Strongly Agree Unsure Disagree Strongly 
Agree Disagree 
,. 
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28. If a person craves drugs they should overcome this by 
sheer willpower. 
Str~ng'ly~--~A~g;~ •• =-----~U~n~s:~~r~e----~D~i~scca~~r~e~e----~s~t"'r~ngly 
Agree Disagree 
29. Injecting drug users should be allowed to inject in 
private. 
Str~-n~g~lyc----c,,-g;~ •• c-----~U~n-s~~r=e----~D~i~sCOa~~r=e=e----~S~t:::r;ngly 
Agree Dis.Jree 
30. It is a waste of time trying to help injecting drug users. 
Str~~n~g~lyc----cAc=g:=e~e----~U~n~s:~=r~e----~D~i~scca~Lr~e~e----~S~t'"r;ngly 
Agree Disagree 
31. If injecting drug use was legal it would not be a problem. 
Str~-n~g~lyc----c,,-g;~.~.----~u~n~s·~~r-e----~D~i~s-a~'-r-e~e----~s~t-r~ngly 
Agree Disagree 
32. Injecting drug use is just plain WTong. 
Str~-n~g~lyc----cAc-g;~.~.----~u~n~s:~~r-e----~D~i~s-a~'-r-e~e----~s~t-r;ngly 
Agree Disagree 
33. Injecting drug use is a natural way of obtaining pleasure 
in human beings. 
Str;n~g~l~yc----A~g==;.~.=-----~u~n'"s;r~ec---~D~,~·s~a~g~=e~ec---~st~r'";ngly 
Agrea Disagree 
DEMOGRAPHIC DETAILS 
Finally we would like to ask some questions about yourself and 
your pharmacy for statistical purposes. 
34. In what year did you register as a pharmacist? 
Year 
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35. How long have you been working as a ph~rmacist? 
Years ------------
36. How long have you been in the present pharmacy? 
Months Years 
37. What is your present age? 
38. Which sex are you? 
1 Male 
2 Female 
39. How many equivalent full time staff are employed at your 
pharmacy? 
40. From the following list of examples which best describes 
the location of your pharmacy? 
1 Central Business District 
2 Regional Shopping centre 
3 Strip type shopping 
4 Neighbourhood shops 
5 Isolated 6 Other (Please specify) ________________________ _ 
41. What are the opening hours of your pharmacy? 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
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42. What is. the largest customer group served by your 
pharmacy? (More than one number may be circled). 
1 Unemployed 
2 Passing trade 
3 Professionals/Office workers 
4 Students 
5 Elderly 
6 Young families 
7 "Alternatives" 
8 Other (Please specify) 
43. What is your postcode? 
Do you have any further comments on the issues in this 
questionnaire or suggested strategies that might be useful for 
pharmacists in dealing with injecting drug users? 
Please tick the box if you would like a summary of the findings 
from this study. 
0 
could you please now place the questionnaire in the stamped 
addressed envelope provided and return to Edith Cowan 
University. 
THANK YOU VERY MUCH FOR YOUR COOPERATION 
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APPENDIX E 
THE SUPPLY OF NEEDLES AND SYRINGES 
TO INJECTING DRUG USERS: 
ATTITUDES AND PRACTICES OF PHARMACISTS 
IN WESTERN AUSTRALIA 
SURVEY OF WESTERN AUSTRALIAN 
PHARMACISTS 
EDITH COW AN UNIVERSITY 
2 Bradford Street 
Mount Lawley W A 6050 
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SURVEY OF WESTERN AUSTRALIAN PHARMACISTS 
Thank you for your assistance in this endeavour. The 
following questionnaire contains 40 brief questions related to 
the provision of needles and syringes. 
"Your pharmacy" refers to the pharmacy in which you are 
currently located. "Injecting drug usersu are individuals 
known or believed to be injecting drugs illicitly. 
Please answer~ questions. 
(Unless specified please circle only one number representing 
the answer you most agree with). 
PUBLIC HEALTH 
The first set of questions concern public health issues in 
Western Australia. We would like to know your thoughts on 
these matters. (Please circle. one number on each scale}. 
1. How serious a health risk to the general public do you 
believe the HIV virus is in Western Australia? 
Not ~t all Not 2v'"e::ry:::---;-;un=-·;:u::r::e;--~s::ce;',-io=u::s;---,.,V;ry 
serious serious serious 
2. How serious a health risk do you believe the HIV virus 
is for injecting drug users in Western Australia? 
Not ~t all Not 2·v"e-ry,----;-;U-n;u,-r-e---=s-e;',-;o::u-s--"'7.'V;ry 
serious serious serious 
3. How serious a health risk to the general public do you 
believe Hepatitis c is in Western Australia? 
Not ~t=-=a"l"l--;N:;:o::t,.-·v':::e=ry::----,.,un::;.u~r=e:---csoce::~:i;-:o:cu:::s---;vc;;cry 
serious serious serious 
4. How serious a health risk do you believe Hepatitis c is 
to injecting drug users in western Australia? 
Not ~t all Not 2v·"e'"'ry,----;-;Uccn:u•~r"'e:--.---s"e~:·,,.,. o"'u"'s---,v~;·ry 
serious serious serious 
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5. Do you think that the use of non sterile injecting 
equipment by injecting drug users represents a 
significant health hazard to the general public? 
1 2 '~--~~~·· 5 Not at all Not very Unsure Significant Very 
significant significant significant 
6. Do you think the use of non-sterile injecting 
equipment by injecting drug users represents a 
significant health hazard to injecting drug users? 
1_ 2 '=----;=::o'' 5 Not at all Not very Unsure Significant Very 
significant significant significant 
7. What role do you think pharmacists should play in 
relation to the prevention of HIV and Hepatitis? {More 
than one number may be circled). 
1 Provide advice, information and counselling. 
2 Provide information and pamphlets on HIV, Hepatitis 
and injecting drug use. 
3 Sell needles and syringes to injecting drug users. 
4 Sell condoms. 
5 Provide free sterile needles and syringes on receipt 
of used equipment. 
6 Pharmacists should play no role. 
7 Other (Please specify) ____________________________ __ 
NEEDLE AND SYRINGE DISTRIBUTION 
The next set of questions concern the.distribution of needles 
and syringes to injecting drug users. 
8. Where do you think injecting drug users should obtain 
needles and syringes from? (More than one number may 
be circled). 
1 Hospitals 
2 Drug treatment agencies 
3 Pharmacies 
4 Police Stations 
5 Doctors' surgeries 
6 Community Health Centres 
7 Outreach vans 
8 Needle Exchanges 
9 Vending Machines 
10 None of the above 
11 Needles and syringes should not be suppli-...d. to 
injecting drug users. 
12 Other (Please specify) 
...... ~ ... \ : 
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9. How do you. think needles 
to injecting drug users? 
circled). 
and syringes should be supplied 
(More than one number may be 
1 Injecting drug users should buy needles and 
syringes. 
2 Injecting drug users should exchange used needles 
and syringes for new equipment. 
3 Needles and syringes should be supplied free to 
injecting drug users. 
4 Needles and syringes should not be supplied at all 
to injecting drug users. 
10. Does your pharmacy have a policy regarding the sale of 
needles and syringes to injecting drug users? 
1 Yes 
2 No 
If Yes: 
lOa. What are the main points of your policy regarding 
the sale of needles and syringes to injecting drug 
users? 
11. Have you had any training regarding the sale of needles 
and syringes to injecting drug users? 
l Yes 
2 No 
If Yes: 
lla. In what year did you have training regarding the 
sale of needles and syringes to injecting drug 
users? 
Year ____ _ 
llb. Which organisation conducted the training regarding 
the sale of needles and syringes to injecting drug 
users? 
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"·~--,...~.,..__.....·-··--
12. Do you support the Health Department of Western 
Australia's strategy to encourage phar.macists to sell 
needles and syringes to injecting drug users for harm 
minimisation reasons? 
1 Yes 
2 No 
CURRENT PRACTICES 
Now we would like to know about your practices in relation to 
the supply of-needles and syringes. The following questions 
relate to the pharmacy in which you are currently located. 
13. Do you sell needles and syringes to customers other than 
those you know or believe to be injecting drugs 
illicitly? 
1 Yes 
2 No 
If Yes: 
l3a. How do you differentiate between injecting drug 
users and other customers in your pharmacy? 
(More than one may be circled) 
1 Appearance 
2 Behaviour 
3 Direct questioning 
4 Reasons given for requiring syringes 
5 'Gut' feeling 
6 Other (Please specify) 
14. Do you intend to supply needles and syringes to injecting 
drug users in the future? 
1 Yes 
2 No 
If yes: 
l4a. For what reason do you intend to change your current 
practice in relation to supplying needles and 
syringes to .injecting drug users? 
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15. Have you sold needles and syringes to injecting drug 
users in the past? 
1 Yes 
2 No (Go to Q 16) 
If yes: 
15a. When did you stop selling needles and syringes to 
injecting drug users? 
Month---- Year-----
15b. Have you experienced a disruptive incident in your 
pharmacy concerning injecting drug users? 
1 No (Go to Q 15c) 
2 Yes (Please specify) _________________ _ 
i. How did you handle the disruptive incident? 
ii. Did the disruptive incident influence your practice 
of selling needles and syringes to injecting drug 
users in any way? 
1 Yes 
2 No 
If Yes: 
iia. In what way did this influence your practice of 
selling needles and syringes to injecting drug 
users? 
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lSc. Were the following factors important in your 
decision to stop selling needles and syringes to 
injecting drug users? (Please circle one number on 
each scale). 
i. Selling needles and syringes had caused disruption 
in my pharmacy. 
Not ~t all Not 2v:-e:-:ry:-:---::Ne"u:c:'ccra'"l,---o;-Im"'p"o=-':tant Ve~ 
important important important 
ii. I was losing too much stock from shoplifting. 
Not ~:-t--:a:-;lc;l--,No;co::;tc''v:-e::ry:cc---;;N:::eu:C:'::-ra:Cl;--o;-Im"p"'o::::-ta::n:;t:----;;V;:::e~ 
important important important 
iii. There were incidents that threatened the safety of 
staff and/or other customers. 
Not ;t all Not 
2
v:-e:-:ry:-:----;;N:ceu::-::'=ra;cl,----,Im=-po=-:tant Ve~ 
important important important 
iv. I was concerned about the legal ramifications. 
Not ; t all Not 
2 
v"'e::ry:cc---;;N:::eu"':'::-ra:cl,---.,-,m::-p:co::--::-t a::n:;t:----;;V;:::e~ 
important important important 
v. I had ethical concerns about appearing to condone 
illicit drug use. 
1 '=::-----,=,''=-----;:=· 5 Not at all Not very Neutral Important Very 
important important important 
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vi. I was concerned about the local community's attitude 
relating to the supply of needles and syringes to 
injecting drug users. 
Not ~~t-a=-1"1;-~N=-=o7t 2~vc"ery=--,N"'e"'"'u~r-a"1;---=rm-p::-o-:·t""a-n"'t---,Vc-e;, 
important important important 
vii. Other (Please specify) 
(Please answer question 16. Although you will find it vezy 
similar to the questions you just answered it is also 
important that we investigate your current reasons for not 
selling needles and syringes to injecting drug users). 
16. How important are the following factors in determining 
your current decision not to sell needles and syringes 
to injecting drug users? (Please circle one number on each 
seal e) . 
16a. Provision of needles and syringes encourages illicit 
drug use. 
Not ;t all Not 
2
v::-e"ry,_---,N:-:eccu:;r-a"1;---,I:-:m::-p-,o:·tant Ve~ 
important important important 
16b. I am concerned about shoplifting in my pharmacy. 
Not ;t all Not 
2
v::-e:-:ry,-----oN:-:eccu;·r-a"1;---,I:-:m::-p-,o:tant Ve~ 
important important important 
16c. I am concerned about possible aggression towards 
staff of the pharmacy. 
Not ;t all Not 
2v~e"ry=c-~N:-:e~u;~r=a::-1;--~I~m=p"'-o:tant Ve~ 
important important important 
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l6d. Because of the current legislation on the supply of 
needles and syringes. 
1 2'=-~~.3-,.--=-·4 5 Not at all Not very Neutral Important Very 
important important important 
16e. MY other customers would complain or stop coming to 
the pharmacy if I sold needles and syringes to 
injecting drug users. 
Not ~ t a 11 Not 2 v-:ce::ry:::----,N:-eu"'g'::r:-a 1;---=rm=p=-o:::·t=-a::n::t:----;,v"'e;, 
important important important 
16f. I don•t want the kind of people who use drugs coming 
into my pharmacy. 
Not .;t.,.-a,-l~l;----,N,-o7t 2'v-:-ec-ry--7N""e-ug'r--al;---:I,-mp-o-:t::a-n::t--~Vc-e;, 
important important important 
l6g. I have not had any requests for needles and syringes. 
Not ~t,--a,-1~1;----,N::o:::-t 2'·vc-=-e=ry::---oNo-eccu;'=r:-a"'l---;I=mp:-o:-:.:-ta"n"t:---;cVcce;, 
important important important 
16h. I am concerned about being prosecuted for providing 
needles and syringes. 
'-.,-,-~=2'--~,--'',--,,---,-4,--.,---.,.,--s Not at all Not very Neutral Important Very 
important important important 
l6i. Other (Please specify) 
17. What would encourage you to sell needles and syringes to 
injecting drug users? 
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18. Are you currently involved in dispensing methadone? 
1 Yes 
2 No 
If Yes: 
l8a. How many clients do you currently supply with 
methadone? 
LEGISLATION 
This section focuses on issues related to current legislation 
and how it impacts on your practice. 
19. What is the current legal status regarding the sale of 
needles and syringes to injecting drug users? 
20. In what way does this influence your practice regarding 
the sale of needles and syringes to injecting drug users? 
ATTITUDES TO INJECTING DRUG USE AND INJECTING DRUG USERS 
This section concerns your attitudes to injecting drug use and 
injecting drug users. (Please circle one number on each scale). 
21. Injecting drug users are mindless pleasure seekeriL 
Str;=n""g"ly::---;;-Ag=·;-oee:----;-u;::n"s~"re:---,D::ic:s"a~·=r-=ee=---;;;s,cr~ngly 
Agree Disagree 
22. Injecting drug use is simply a different kind of life-
style that should not be condemned. 
str;""ng~l""y,.---cA"g;.,-ee=-_ ---,u==n=s~=re=---,o"i"'s"a~·=r-=-ee:---cso:t=~~ngly 
Agree Disagree 
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23. 
24. 
Injecting drug users are not capable of changing. 
1 2 3 4 5 
Strongly Agree Unsure Disagree strongly 
A£:;:..·ee Disagree 
Injecting drug users are criminals by nature. 
str~=n=g"lyc.---~A~g~r=e=e----~u~n:::s:~=r=e----~D~i~s"'a~=r=e=e----~s~t"'r;ngly 
Agree Disagree 
25. If a person craves drugs they should overcome this by 
sheer willpower. 
Str;=n=g"lyc---~A~g:~~.=.----~U~n~s•~-r=e----~D~i=s--a~-r=e-e _____ S~t--r~ngly 
Agree Disagree 
26. Injecting drug users should be allowed to inject in 
private. 
Str;-n-g7lyc---A=g-·~=ee;:------;u;:n:::s:~=r=e-----;D~i"s"'a~·=r=e=e-----:S;;tc:r~ngly 
Agree Disagree 
27. It is a waste of time trying to help injecting drug users. 
Str;::n::g.,-lyc.----A.,-g::~:e::e----~U;:n:::s:~::r::e-----;D~i-=s::ca~·=r=e=e-----;S;;tc:r;ngly 
Agree Disagree 
28. If injecting drug use was legal it would not be a problem. 
Str;-ng~ly----~A-g;-.-.----~u~n~s•~-r-e----~D~i-s-ca~-r-e_e _____ S~t--r;ngly 
Agree Disagree 
29. Injecting drug use is just plain wrong. 
str;=ng=lyc---~,-,-g·;-.=.----~U~n~s•~=r=e----~D~i"s-=a~=r=ee,---~s=rr=;•ngly 
Agree Disagree 
30. Injecting drug use is a natural way of obtaining pleasure 
in human beings. 
Str~n~g~l~Y,---~,=:g;e::ec-----u~n~s~~r~e~---;D~l~·s::a~g~=e::ec---~s~tr:::ngly 
Agree Disagree 
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DEMOGRAPHIC DE~AILS . 
Finally we would like to ask some questions about yourself and 
your pharmacy for statistical purposes. 
31. In what year did you graduate as a pharmacist? 
Year -------------
32. How long have you been working as a pharmacist? 
Years 
33. How long have you been in the present pharmacy? 
Months Years 
34. What is your present age? 
Years 
35. Which sex are yet•? 
1 Male 
2 Female 
36. How many equivalent full time staff are employed at your 
pharmacy? 
37. From the following list of examples which best describes 
the location of your pharmacy? 
1 central Business District 
2 Regional Shopping Centre 
3 Strip type shopping 
4 Neighbourhood shops 
5 Isolated 6 Other (Please specify) ________________________ _ 
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38. What are the opening hours of your pharmacy? 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
39. What is the largest customer group served by your 
pharmacy? (More than one may be circled). 
1 Unemployed 
2 Passing trade 
3 Professionals/Office workers 
4 Students 
5 Elderly 
6 Young families 
7 "Alternatives'' 
B Other (Please specify) 
40. What is your postcode? 
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Do you have any further comments on the issues in this 
questionnaire or suggested strategies that might be useful for 
pharmacists in dealing with injecting drug users? 
Please tick the box if you would like a summary of the findings 
from this study. 
D 
Could you please now place the questionnaire in the st~ped 
addressed envelope provided and return to Edith cowan 
University. 
THANK YOU VERY MUCH FOR YOUR COOPERATION 
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APPENDIXF 
~BE SUPPLY OF NEEDLES AND SYRINGES ~0 INJEC~ING DRUG USERS: 
A~~I~UDES AND PRACTICES OF PBARMACIS~S IN WES~ERN AUS~RALIA 
PRE-~ES~ OF QUES~IONNAIRE 
Thank you for agreeing to participate in the pre-testing of 
this questionnaire. This is one of two questionnaires 
developed, one of which will be forwarded to pharmacists 
depending on their supply practices. A preceding telephone 
call to pharmacists will determine this. It is the purpose 
of this pre-test stage to determine the time the 
questionnaire takes for completion and the clarity of the 
questions. No further questions will be included but 
adjustments will be made where necessary. 
Please answer questions by adopting the role of seller, 
non-seller or past seller as indicated on the top of the 
questionnaire. 
Time to complete ------------
Please comment on any difficulties, ambiguities etc., you 
found with any of the questions. Suggestions for 
improvement of the questionnai~e are also welcome. 
Please write on back of the page if you have further 
comments. 
Your assistance is very much appreciated. Thank you. 
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APPENDIX H 
Dear 
EDITH COWAN 
UNIVERSITY 
PERTH WESTERN AUSTRALIA 
JOONOALUP CAMPUS 
Joondalup Drive. Joondalup 
Western Australia 6027 
Telephone (09) 405 5555 
Facsimile (09) 300 1257 
RE: THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING DRUG 
USERS: ATTITUDES AND PRACTICES OF PHARMACISTS IN WESTERN 
AUSTRALIA. 
In Western Australia, the supply of needles and syringes to injecting drug users 
by pharmacists, and pharmacists attitudes about these issues has not been 
extensively examined. The purpose of the present study is to investigate these 
issues, anti provide you with an opportunity to voice your own views. 
One hundred and thirty pharmacists from Western Australia have been 
randomly selected to take part in the study. In order that the results be 
genuinely representative it is important that each questionnaire be completed 
and returned. Your input is both valuable and appreciated. 
You may be assured of complete confidentiality. The questionnaire has an 
identification number for mailing purposes only. This is to check your name off 
the mailing list when the questionnaire is returned. Overall results will be 
collated, but individual respondents will not be identified. 
A summary of the findings will be made available to both the Pharmaceutical 
Council and the Pharmacy Guild. If you would like to receive your 0wn copy 
please tick the box at the end of the questionnaire. 
Please return the completed questionnaire in the stamped addressed envelope 
by 
If you have any questions please telephone June Newbey on (09) 445-2139 or 
Celia Wilkinson (Edith Cowan University) on (09) 370-6329. 
Thank you for y.,ur assistance in this research project. 
Yours faithfully 
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M>PENDJX I 
Fimt Follow-up Telephone Reminder Call 
Hello, this is June Newbey speaking from Edith Cowan University. 
I am calling regarding the questionnaire I forwarded to you concerning the supply 
of needles and syringes to injecting drug users. Did you receive it? 
H yes: As I haven't yet received it back I wonder whether you have had the 
opportunity to complete it. I realize you may be vel)' busy so this is just a 
reminder. Your answers are vel)' important to us and I would appreciate it if you 
could return it as soon as possible. 
If you require another questionnaire I will forward it to you. Thank you vel)' 
much. Goodbye. 
H No: I am SOfl)' it did not reach you. May I forwwd another questionnaire to 
you? 
HYes: Thank you. Could you please tell me your address so I can check that the 
address I have for you is accurate. Thank you vel)' much. I will forward another 
questionnaire tomorrow. I would appreciate it if could complete and return it as 
soon as possible. Goodbye. 
H no: Thank you for your time. Goodbye. 
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APPENDIX J 
Second Follow-up Telephone RemiDder Call 
Hello. This is June Newhey from Edith Cowan University. As yet I have not 
received the questionnaire I posted to you concemiDg the supply of needles and 
syringes to injecting drug users. 
Your answers are very important to ensure the results are representative of 
phannacists' views. CouJd you please return the questionnaire as soon as possible? 
Thank you ver; much for your assistance. 
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APPENDIX K 
4/10/94 
Dear 
EDITH COWAN 
UNIVERSITY 
PERTH WESTERN AUSTRALIA 
JOONOALUP CAMPUS 
Joondalup Drive, Joondalup 
Western Australi~ 6027 
Telephone {09) 405 5555 
Facsimile (09) 300 1257 
RE: "TilE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING 
DRUG USERS: ATTITUDES AND PRACTICES OF PHARMACISTS 
IN WESTERN AUSTRALIA" 
We are writing to express our appreciation for your participation in the research 
we are currently conducting regarding the supply of needles and syringes to 
injecting drug users. The response received was overwhelming and indicates to 
us the importance of this topic to pharmacists and the concern they have about 
these issues. By completing and returning the questionnaire you have helped 
ensure that the findings better represent the views of pharmacists in Western 
Australia. 
The data analysis is currently being undertaken and the research report prepared. 
This is expected to be finalised towards the end of the year when your copy of the 
results will be forwarded to you. 
Thank very much for your cooperation in this important social research. 
Yours faithfully, 
June Newbey, Honours Student 
Celia Wilkinson, Lecturer- Health Studies 
JOONOALUPCAMPUS 
Joon!lalup Or Ne. Joondatup 
Western Austra11a 5027 
Telephone (09) 405 5555 
MOUNT LAWLEV CAMPUS 
2 Bradford Street. Mount Lawley 
Western Australra 6050 
Telephone 1091 370 6111 
CHURCHLANDS CAMPUS 
i'carson S!leel Churchlancls 
Western At1srraha 5018 
Telephone r091 273 8333 
CLAREMONT CAMPUS 
Goldsworthy Road. Claremont 
Western Austra11a 6010 
Telephone 109) 273 8333 
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BUNBURY CAMPUS 
Robert~on Drive. Bunbury 
Western Austro:oa 6230 
Telephone (097) BO 7777 
APPENDIX L 
4/10/94 
Dear 
EDITH COWAN 
UNIVERSITY 
WEfTERN AUSTRALIA 
BUNBURY CAMPUSi 
Robertson Drive, Buntmry 
Western Australia 6230 
Telephone (097) 81) 7777 
Facsimile (097) 21 6994 
RE: ''THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING 
DRUG USERS: A TI1TUDES AND PRACTICES OF PHARMACISTS 
IN WESTERN AUS1TtALIA" 
We are writing to express our appreciation for your p•Iticipation in the research 
we are currently conducting regarding the supply of needles and syringes to 
injecting drug users. The response received was overwhelming and indicates to 
us the importance of this topic to pharmacists and the concern they have about 
these issues. By completing and returning the questionnaire you have helped 
ensure that the findings better represent the views of pharmacists in Western 
Australia. 
The data analysis is currently bt.ing undertaken and the research report prepared. 
This is expected to be finalised towards the end of the year when a copy of the 
results will be made available to both The Pharmaceutical Council of Western 
Australia and the Pharmacy Guild of Australia. 
Thank very much for your cooperation in this important social research. 
Yours faithfully, 
Cella Wilkinson, Lecturer - Health Studies. 
JOONOALUP CAMPUS 
Joon~alup Drive. Joondalup 
Weslern Australia 6027 
Tel~phooe (09) 405 5555 
MOurn LAWLEY CAMPUS 
2 Bradford Street. Mountlawley 
W~stern Australia 6050 
Telephone \09) 370 5111 
CHURCHLANOS CAMPUS 
Pearson Sireet, Ctwrchlancfs 
Weslern Austral•a 5018 
Telepllone {09)383 8333 
ClARE MONT CAMPUS 
Goldswor1hy Road. Claremon1 
Western Austral:a 6010 
Telephone 109) 3B3 0333 
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BUNBUAY CAMPUS 
Aobertson Drive. Bunbury 
Western Australia 6230 
Telephone (097) BO 7777 
APPENDIX M 
4/10/94 
The Director 
National Services Division 
Pharmacy Guild of Australia 
40 Burwood Road 
HAWTHORNE 
Victoria 3122 
EDITH COWAN 
UNIVERSITY 
PERTH WESTERN AUSTRALIA 
JOONOALUP CAMPUS 
Joondalup Drive, Joondalup 
Western Australia 6027 
Telephone (09) 405 5555 
Facsimile {09) 3001257 
RE: "THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING 
DRUG USERS: ATTITUDES AND PRACTICES OF 
PHARMACISTS 
IN WESTERN AUSTRALIA" 
Dear Mr Rees, 
The data gathering process in the above study has been concluded. The sample of 
130 pharmacists selected to take part have shown ovenvhelming cooperation with 
this project. A response rate of 89% has been achieved, an excellent return for a 
survey of this kind. Such a response ensures that the findings will better represent 
the views of Western Australian pharmacists. 
Approval of the survey by The Pharmacy Guild helped legitimise the study and 
was undoubtedly a very important factor in achieving this high response rate. The 
assistance given by you and your organisation is very much appreciated and has 
aided the smooth execution of the data gathering process. 
The data analysis is currently being undertaken and the research report prepared. 
This is expected to be finalised towards the end of the year when a copy of the 
resuits will be forwarded to you. 
Yours faithfuily, 
C::::Zs Student 
Celia Wilkinson, Lecturer- Health Studies 
JOQriOAlUP CAMPUS 
Joondalup Dri1·e. Joondalup 
Westem Austr~t1a 6027 
T~reoMne {09t ~05 5555 
MOUNT LAWlEY CAMPUS 
2 Bradtord StreeL Motml Lawley 
\Vestem Ausbillra 6050 
T e'eph o~e ros·, 37 0 61 t 1 
CHUACHLANOS \.AM PUS 
Peorson S1ree1. Churchlands 
lNestern Australia 601B 
Tete~honc wg)273 8333 
CLAREMONT CAMPUS 
Gotdsworthy Road. Clare m ant 
Western Australia 6010 
T~lephone (091273 8333 
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BUNBURY CAMPUS 
Robertson Drive. Bunbury 
Western Austral1a 6230 
Telephone (0971 ao 7777 
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~--_c._," 
4/10/94 
The President 
Pharmacy Guild of Australia 
Hay Street 
WEST PERTH 6004 
APPENDIX N 
EDITH COWAN 
UNIVERSITY 
PERTH WESTERN AUSTRALIA 
JOONDALUP CAMPUS 
Joondalup Drive, Joondalup 
Western Australia 6027 
Telephone (09) 405 5555 
Facsimile (09) JOG 1257 
RE: "THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING 
DRUG USERS: ATTITUDES I..ND PRACTICES OF PHARMACISTS 
IN WESTERN AUSTRALIA" 
Dear Mr Zafer, 
The data gathering process in the above study has been concluded. The sample of 
130 pharmacists selected to take part have shown overwhelming cooperation with 
this project. A response rate of 89% has been achieved, an excellent return for a 
survey of this kind. Such a response ensures that the findings will better represent 
the views of Western Australian pharmacists. 
Approval of the survey by The Pharmacy Guild helped legitimise the study and 
was undoubtedly a very important factor in achieving this high response rate. The 
assistance given by your organisation is very much appreciated and has aided the 
smooth execution of the data gathering process. 
The data analysis is currently being undertaken and the research report prepared. 
This is expected to be finalised towards the end of the year when a copy of the 
results will be forwarded to you. 
Yours faithfully, 
June New bey, Honours Student 
Celia Wllkinson, Lecturer- Health Studies 
JOONDALUP CAMPUS 
JDondalup Onve. JooMalup 
W~stero Australra 6027 
~errpnone r09l 405 ~555 
MOUNT LAWLEY CAMPUS 
2 Bradlorc! Street Mount Lawley 
Wester~ Austrolra 6050 
Telephone IQ913i0 6111 
......,. _ ...,........,.,~------~--· -----
CHURCHLANOS r.AMPUS 
Pearson Stleet ChurchiJ.nds 
\llestem Austratra 6018 
TeicPhone r09r 2i3 8333 
CLAREMONT CAMPUS 
Goldsworthy Road. Claremon1 
Western Australia 6010 
T~lephone 109) 2i3 8333 
152 
BlJNBUAY Ci\.MPUS 
Robertson Ori~e. Bunbury 
We~tern i\.ustra1'1a 6230 
Telephone r097) 80 7777 
4/10/94 APPENDIX 0 
The Registrar 
Pharmaceutical Council of Western Australia 
21 Hamilton Street 
SUBIACO 6008 
EDITH COWAN 
UNIVERSITY 
PERTH WESTERN AUSTRALIA 
JOONDALUP CAMPUS 
Joondalup Drive, Joondalup 
Western Australia 6027 
Telephone (09) 405 5555 
Facsimile (09) 3001257 
RE: "THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING 
DRUG USERS: ATTITUDES AND PRACTICES OF PHARMACISTS 
IN WESTERN AUSTRALIA" 
Dear Mr Brennan, 
The data gathering process in the above survey has been concluded. The sample 
of 130 pharmacists selected to take part have shown overwhelming cooperation 
with this project. A response rate of 89% has been achieved, an excellent return 
for a survey of this kind. Such a response ensures that the findings will better 
represent the views of Western Australian pharmacists. 
The assistance given by your organisation in the planning of the study and 
preparation of the questionnaire are very much appreciated and have aided the 
smooth execution of the data gathering process. 
The data analysis is currently being undertaken and the research report prepared. 
This is expected to be finalised towards the end of the year when a copy of the 
results will be forwarded to you. 
Yours faithfully, 
June New bey, Honours Student 
Celia Wilkinson, Lecturer Health Studies. 
JOONOAlUP CAMPUS 
Joondalup Orrve. Joondalup 
Western Australra S027 
Telephone r09) 405 5555 
MOUNT LAWlEV CAMPUS 
2 Bradlord St1ert. l~ount L~I'IICy 
Western AuSir~lra 6050 
Te!eoMne 1091370 6111 
CHURCHLANOS r.AMPUS 
Pparson Street. Churchlands 
\lie stern Australra 60111 
TelePhone {09)2i3 B333 
CLAREMONT CAMPUS 
Goldswonhy Road. Cloremonl 
Western Australia 60t0 
lel~phone (091 273 8333 
!53 
8UNBURY CAMPUS 
Rohenson Drive, B11nbury 
west em Austrat'a 6230 
Telephone (097180 7777 
APPENDIX P 
Flowchart of Pharmacists' Response 
Population of WA Community Phannacists 
Total Metropolitan Returned 
n =7e 
= 
Random Sample 
N= 130 
Total Country Returned 
n =42 
" NR = Not Received (Pharmacist claimed to have returned the questionnaire but it was not received). 
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